Announcements

September is designated as “Thyroid Cancer Awareness Month”, with various global activities that highlight and increase awareness of thyroid cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of thyroid cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Papillary Thyroid Cancer Prognosis: An Evolving Field”
by Salvatore Ulisse, Enke Baldini, Augusto Lauro, Daniele Pironi, Domenico Tripodi, Eleonora Lori, Iulia Catalina Ferent, Maria Ida Amabile, Antonio Catania, Filippo Maria Di Matteo et al.
Cancers 2021, 13(21), 5567; https://doi.org/10.3390/cancers13215567
Available online: https://www.mdpi.com/2072-6694/13/21/5567

“Fluorescence Image-Guided Surgery for Thyroid Cancer: Utility for Preventing Hypoparathyroidism”
by Marco Stefano Demarchi, Barbara Seeliger, Jean-Christophe Lifante, Pier Francesco Alesina and Frédéric Triponez
Cancers 2021, 13(15), 3792; https://doi.org/10.3390/cancers13153792
Available online: https://www.mdpi.com/2072-6694/13/15/3792

“Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer”
by Marotta Vincenzo, Maurizio Bifulco and Mario Vitale
Cancers 2021, 13(15), 3785; https://doi.org/10.3390/cancers13153785
Available online: https://www.mdpi.com/2072-6694/13/15/3785

“Deep Learning Fast Screening Approach on Cytological Whole Slides for Thyroid Cancer Diagnosis”
by Yi-Jia Lin, Tai-Kuang Chao, Muhammad-Adil Khalil, Yu-Ching Lee, Ding-Zhi Hong, Jia-Jhen Wu and Ching-Wei Wang
Cancers 2021, 13(15), 3891; https://doi.org/10.3390/cancers13153891
Available online: https://www.mdpi.com/2072-6694/13/15/3891

“Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?”
by Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, Agnieszka Mikuła, Maria Greniuk and Jerzy Rudnicki
Cancers 2022, 14(15), 3643; https://doi.org/10.3390/cancers14153643
Available online: https://www.mdpi.com/2072-6694/14/15/3643

“Translational Utility of Liquid Biopsies in Thyroid Cancer Management”
by Ayanthi A.Wijewardene, Marthe Chehade, Matti L. Gild, Roderick J. Clifton-Bligh and Martyn Bullock
Cancers 2021, 13(14), 3443; https://doi.org/10.3390/cancers13143443
Available online: https://www.mdpi.com/2072-6694/13/14/3443

“Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells”
by Fang-Ping Kung, Yun-Ping Lim, Wen-Ying Chao, Yi-Sheng Zhang, Hui-I Yu, Tsai-Sung Tai, Chieh-Hsiang Lu, Shu-Hsin Chen, Yi-Zhen Li, Pei-Wen Zhao et al.
Cancers 2021, 13(17); 4266. https://doi.org/10.3390/cancers13174266
Available online: https://www.mdpi.com/2072-6694/13/17/4266

“Molecular Genetics of Follicular-Derived Thyroid Cancer”
by Elisabetta Macerola, Anello Marcello Poma, Paola Vignali, Alessio Basolo, Clara Ugolini, Liborio Torregrossa, Ferruccio Santini and Fulvio Basolo
Cancers 2021, 13(5); 1139; https://doi.org/10.3390/cancers13051139
Available online: https://www.mdpi.com/2072-6694/13/5/1139

“Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer“
by Marina Muzza, Gabriele Pogliaghi, Carla Colombo, Erika Carbone, Valentina Cirello, Sonia Palazzo, Francesco Frattini, Davide Gentilini, Giacomo Gazzano, Luca Persani et al.
Cancers 2022, 14(23), 5857; https://doi.org/10.3390/cancers14235857
Available online: https://www.mdpi.com/2072-6694/14/23/5857

“Current Management of Bone Metastases from Differentiated Thyroid Cancer”
by Satoshi Kato, Satoru Demura, Kazuya Shinmura, Noriaki Yokogawa, Takaki Shimizu and Hiroyuki Tsuchiya
Cancers 2021, 13(17), 4429; https://doi.org/10.3390/cancers13174429
Available online: https://www.mdpi.com/2072-6694/13/17/4429

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

Conference: RSNA 2023
Organization: The Radiological Society of North America
Date: 26–29 November 2023
Place: McCormick Place, 2301 S. Lake Shore Drive, Chicago, IL 60616 USA
Booth: #1103

The Radiological Society of North America (RSNA) is a non-profit organization. RSNA’s annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas, and see the latest technology in action. This year’s theme—Leading through Change—focuses on how radiology professionals can be intentional and proactive while leading teams and organizations through change.

The following MDPI journals will be represented as exhibitors:

• Diagnostics;
• JPM;
• Tomography;
• JCM;
• Osteology;
• Radiation;
• Cancers.

If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.rsna.org/annual-meeting.

September is designated as “Prostate Cancer Awareness Month”, with various global activities that highlight and increase awareness of prostate cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of prostate cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters”
by Piotr Woźnicki, Niklas Westhoff, Thomas Huber, Philipp Riffel, Matthias F. Froelich, Eva Gresser, Jost von Hardenberg, Alexander Mühlberg, Maurice Stephan Michel, Stefan O. Schoenberg et al.
Cancers 2020, 12(7), 1767; https://doi.org/10.3390/cancers12071767
Available online: https://www.mdpi.com/2072-6694/12/7/1767

“Immunotherapy in Prostate Cancer”
by Emily K. Fay and Julie N. Graff
Cancers 2020, 12(7), 1752; https://doi.org/10.3390/cancers12071752
Available online: https://www.mdpi.com/2072-6694/12/7/1752

“The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis”
by Francesco Bonollo, George N. Thalmann, Marianna Kruithof-de Julio and Sofia Karkampouna
Cancers 2020, 12(7), 1887; https://doi.org/10.3390/cancers12071887
Available online: https://www.mdpi.com/2072-6694/12/7/1887

“Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance”
by Maddison Archer, Navneet Dogra and Natasha Kyprianou
Cancers 2020, 12(10), 2984; https://doi.org/10.3390/cancers12102984
Available online: https://www.mdpi.com/2072-6694/12/10/2984

“VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer”
by Daniela Barros-Silva, João Lobo, Catarina Guimarães-Teixeira, Isa Carneiro, Jorge Oliveira, Elena S. Martens-Uzunova, Rui Henrique and Carmen Jerónimo
Cancers 2020, 12(4), 771; https://doi.org/10.3390/cancers12040771
Available online: https://www.mdpi.com/2072-6694/12/4/771

“BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside”
by Stergios Boussios, Elie Rassy, Michele Moschetta, Aruni Ghose, Sola Adeleke, Elisabet Sanchez, Matin Sheriff, Cyrus Chargari and Nicholas Pavlidis
Cancers 2022, 14(16), 3888; https://doi.org/10.3390/cancers14163888
Available online: https://www.mdpi.com/2072-6694/14/16/3888

“Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer”
by Yi-Ting Wang, Tujin Shi, Sudhir Srivastava, Jacob Kagan, Tao Liu and Karin D. Rodland
Cancers 2020, 12(9), 2335; https://doi.org/10.3390/cancers12092335
Available online: https://www.mdpi.com/2072-6694/12/9/2335

“Immune Checkpoint Inhibitors in Prostate Cancer”
by Shobi Venkatachalam, Taylor R. McFarland, Neeraj Agarwal and Umang Swami
Cancers 2020, 13(9), 2187; https://doi.org/10.3390/cancers13092187
Available online: https://www.mdpi.com/2072-6694/13/9/2187

“Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer”
by Asta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland and Roy Hartvig Larsen
Cancers 2020, 13(4), 779; https://doi.org/10.3390/cancers13040779
Available online: https://www.mdpi.com/2072-6694/13/4/779

“Influence of Intratumor Microbiome on Clinical Outcome and Immune Processes in Prostate Cancer”
by Jiayan Ma, Aditi Gnanasekar, Abby Lee, Wei Tse Li, Martin Haas, Jessica Wang-Rodriguez, Eric Y. Chang, Mahadevan Rajasekaran and Weg M. Ongkeko
Cancers 2020, 12(9), 2524; https://doi.org/10.3390/cancers12092524
Available online: https://www.mdpi.com/2072-6694/12/9/2524

You are welcome to submit relevant papers to the journal Cancers. For more information, contact us at [email protected].

Cancers Editorial Office

MDPI will attend the 13th Member Congress of the Chinese Society of Biochemistry and Molecular Biology and 2023 National Academic Congress. This event will be held from 19 to 22 October 2023 in Hefei, China, and is hosted by the Chinese Society of Biochemistry and Molecular Biology.

This event includes invited reports of the conference, branch (special topic) reports, and posters. The theme of this conference is gene expression and regulation; RNA function and regulation; protein modification and function; metabolic homeostasis and networks; frontier technology and application, etc.

The following MDPI journals will be represented:

• Biomolecules (leading);
• Genes (leading);
• IJMS (leading);
• Cancers;
• Cells;
• Pharmaceutics;
• CIMB;
• Biology;
• Symmetry.

If you plan on attending this conference, please feel free to stop by our booth (#C07) and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.csbmb.org.cn/2023/.

We are delighted to share some highly cited papers on hepatocellular carcinoma research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma”
by Hyuk Moon and Simon Weonsang Ro
Cancers 2021, 13(12), 3026; https://doi.org/10.3390/cancers13123026
Available online: https://www.mdpi.com/2072-6694/13/12/3026

“Emerging Therapies for Hepatocellular Carcinoma (HCC)”
by Eesha Chakraborty and Devanand Sarkar
Cancers 2022, 14(11), 2798; https://doi.org/10.3390/cancers14112798
Available online: https://www.mdpi.com/2072-6694/14/11/2798

“Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy”
by Konstantinos Arvanitakis, Triantafyllia Koletsa, Ioannis Mitroulis and Georgios Germanidis
Cancers 2022, 14(1), 226; https://doi.org/10.3390/cancers14010226
Available online: https://www.mdpi.com/2072-6694/14/1/226

“The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma”
by Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U. Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand et al.
Cancers 2022, 14(1), 186; https://doi.org/10.3390/cancers14010186
Available online: https://www.mdpi.com/2072-6694/14/1/186

“Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience”
by Maen Abdelrahim, David Victor, Abdullah Esmail, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish Saharia, Robert McMillan, Joy N. Fong et al.
Cancers 2022, 14(3), 650; https://doi.org/10.3390/cancers14030650
Available online: https://www.mdpi.com/2072-6694/14/3/650

“Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances”
by Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernáez-Alsina, Carlos Cuño, Pablo García de Frutos, Anna Colell, Montserrat Marí and Albert Morales
Cancers 2022, 14(3), 621; https://doi.org/10.3390/cancers14030621
Available online: https://www.mdpi.com/2072-6694/14/3/621

We hope this announcement will provide useful information for this field.

September is designated as “Blood Cancer Awareness Month”, with various global activities that highlight and increase awareness of blood cancers for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of blood cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia”
by Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P. González-Rodríguez, Ángel R. Payer, Esther González-García, Alejandro López-Soto and Segundo Gonzalez
Cancers 2021, 13(9), 2112; https://doi.org/10.3390/cancers13092112
Available online: https://www.mdpi.com/2072-6694/13/9/2112

“The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression”
by Almudena García-Ortiz, Yaiza Rodríguez-García, Jessica Encinas, Elena Maroto-Martín, Eva Castellano, Joaquín Teixidó and Joaquín Martínez-López
Cancers 2021, 13(2), 217; https://doi.org/10.3390/cancers13020217
Available online: https://www.mdpi.com/2072-6694/13/2/217

“Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study”
by Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Chara Giatra, Ioannis Asimakopoulos, Maria Dimou, Aimilia D. Sklirou, Ioannis Ntanasis-Stathopoulos, Ismini Darmani, Alexandros Briasoulis et al.
Cancers 2021, 13(17), 4480; https://doi.org/10.3390/cancers13174480
Available online: https://www.mdpi.com/2072-6694/13/17/4480

“Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma”
by Ichiro Hanamura
Cancers 2021, 13(2), 256; https://doi.org/10.3390/cancers13020256
Available online: https://www.mdpi.com/2072-6694/13/2/256

“Janus Kinases in Leukemia”
by Juuli Raivola, Teemu Haikarainen, Bobin George Abraham and Olli Silvennoinen
Cancers 2021, 13(4), 800; https://doi.org/10.3390/cancers13040800
Available online: https://www.mdpi.com/2072-6694/13/4/800

“The Role of Tumor-Associated Macrophages in Hematologic Malignancies”
by Emanuele Cencini, Alberto Fabbri, Anna Sicuranza, Alessandro Gozzetti and Monica Bocchia
Cancers 2021, 13(14), 3597; https://doi.org/10.3390/cancers13143597
Available online: https://www.mdpi.com/2072-6694/13/14/3597

“MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia”
by Katerina Katsaraki, Paraskevi Karousi, Pinelopi I. Artemaki, Andreas Scorilas, Vasiliki Pappa, Christos K. Kontos and Sotirios G. Papageorgiou
Cancers 2021, 13(4), 593; https://doi.org/10.3390/cancers13040593
Available online: https://www.mdpi.com/2072-6694/13/4/593

“Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment”
by Susanne Ghandili, Martin Schönlein, Marc Lütgehetmann, Julian Schulze zur Wiesch, Heiko Becher, Carsten Bokemeyer, Marianne Sinn, Katja C. Weisel and Lisa B. Leypoldt
Cancers 2021, 13(15), 3800; https://doi.org/10.3390/cancers13153800
Available online: https://www.mdpi.com/2072-6694/13/15/3800

“Stromal Cells Serve Drug Resistance for Multiple Myeloma via Mitochondrial Transfer: A Study on Primary Myeloma and Stromal Cells”
by Zsolt Matula, Gábor Mikala, Szilvia Lukácsi, János Matkó, Tamás Kovács, Éva Monostori, Ferenc Uher and István Vályi-Nagy
Cancers 2021, 13(14), 3461; https://doi.org/10.3390/cancers13143461
Available online: https://www.mdpi.com/2072-6694/13/14/3461

“FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review”
by Aleksandra Sochacka-Ćwikła, Marcin Mączyński and Andrzej Regiec
Cancers 2022, 14(1), 87; https://doi.org/10.3390/cancers14010087
Available online: https://www.mdpi.com/2072-6694/14/1/87

You are welcome to submit relevant papers to the journal Cancers. For any questions, feel free to contact us.

Cancers Editorial Office

September is designated as “Gynaecological Cancer Awareness Month”, with various global activities that highlight and increase awareness of gynaecological cancers for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of gynaecological cancers, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“Immunotherapy and Its Development for Gynecological (Ovarian, Endometrial and Cervical) Tumors: From Immune Checkpoint Inhibitors to Chimeric Antigen Receptor (CAR)-T Cell Therapy”
by Giuseppe Schepisi, Chiara Casadei, Ilaria Toma, Giulia Poti, Maria Laura Iaia, Alberto Farolfi, Vincenza Conteduca, Cristian Lolli, Giorgia Ravaglia, Nicole Brighi et al.
Cancers 2021, 13(4), 840; https://doi.org/10.3390/cancers13040840
Available online: https://www.mdpi.com/2072-6694/13/4/840

“Fertility-Sparing Surgery in Gynecologic Cancer: A Systematic Review”
by Teska Schuurman, Sanne Zilver, Sanne Samuels, Winnie Schats, Frédéric Amant, Nienke van Trommel and Christianne Lok
Cancers 2021, 13(5), 1008; https://doi.org/10.3390/cancers13051008
Available online: https://www.mdpi.com/2072-6694/13/5/1008

“Small Non-Coding-RNA in Gynecological Malignancies”
by Shailendra Kumar Dhar Dwivedi, Geeta Rao, Anindya Dey, Priyabrata Mukherjee, Jonathan D. Wren and Resham Bhattacharya
Cancers 2021, 13(5), 1085; https://doi.org/10.3390/cancers13051085
Available online: https://www.mdpi.com/2072-6694/13/5/1085

“The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer”
by Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama, Claudio Tiribelli and Devis Pascut
Cancers 2021, 13(5), 1168; https://doi.org/10.3390/cancers13051168
Available online: https://www.mdpi.com/2072-6694/13/5/1168

“Carbonic Anhydrase IX Promotes Human Cervical Cancer Cell Motility by Regulating PFKFB4 Expression”
by Min-Chieh Hsin, Yi-Hsien Hsieh, Yi-Hsuan Hsiao, Pei-Ni Chen, Po-Hui Wang and Shun-Fa Yang
Cancers 2021, 13(5), 1174; https://doi.org/10.3390/cancers13051174
Available online: https://www.mdpi.com/2072-6694/13/5/1174

“Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data”
by Simona Duranti, Antonella Pietragalla, Gennaro Daniele, Camilla Nero, Francesca Ciccarone, Giovanni Scambia and Domenica Lorusso
Cancers 2021, 13(9), 2089; https://doi.org/10.3390/cancers13092089
Available online: https://www.mdpi.com/2072-6694/13/9/2089

“Molecular and Cellular Mechanisms of Metformin in Cervical Cancer”
by Ya-Hui Chen, Po-Hui Wang, Pei-Ni Chen, Shun-Fa Yang and Yi-Hsuan Hsiao
Cancers 2021, 13(11), 2545; https://doi.org/10.3390/cancers13112545
Available online: https://www.mdpi.com/2072-6694/13/11/2545

“Overview of Immune Checkpoint Inhibitors in Gynecological Cancer Treatment”
by Boštjan Pirš, Erik Škof, Vladimir Smrkolj and Špela Smrkolj
Cancers 2022, 14(3), 631; https://doi.org/10.3390/cancers14030631
Available online: https://www.mdpi.com/2072-6694/14/3/631

“Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?”
by Saikat Mitra, Mashia Subha Lami, Avoy Ghosh, Rajib Das, Trina Ekawati Tallei, Fatimawali, Fahadul Islam, Kuldeep Dhama, M. Yasmin Begum, Afaf Aldahish et al.
Cancers 2022, 14(3), 759; https://doi.org/10.3390/cancers14030759
Available online: https://www.mdpi.com/2072-6694/14/3/759

“Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models”
by Ha-Yeon Shin, Eun-ju Lee, Wookyeom Yang, Hyo Sun Kim, Dawn Chung, Hanbyoul Cho and Jae-Hoon Kim
Cancers 2022, 14(3), 829; https://doi.org/10.3390/cancers14030829
Available online: https://www.mdpi.com/2072-6694/14/3/829

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

September is designated as “Childhood Cancer Awareness Month”, with various global activities that highlight and increase awareness of childhood cancer for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of childhood cancer, published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of relevant papers can be seen below:

“The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia”
by Jonathan Lukas Lühmann, Marie Stelter, Marie Wolter, Josephine Kater, Jana Lentes, Anke Katharina Bergmann, Maximilian Schieck, Gudrun Göhring, Anja Möricke, Gunnar Cario et al.
Cancers 2021, 13(17), 4388; https://doi.org/10.3390/cancers13174388
Available online: https://www.mdpi.com/2072-6694/13/17/4388

“Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)”
by Margot Gautier, Cécile Thirant, Olivier Delattre and Isabelle Janoueix-Lerosey
Cancers 2021, 13(12), 2904; https://doi.org/10.3390/cancers13122904
Available online: https://www.mdpi.com/2072-6694/13/12/2904

“The Microbiome in Childhood Acute Lymphoblastic Leukemia”
by Marina Oldenburg, Nadine Rüchel, Stefan Janssen, Arndt Borkhardt and Katharina L. Gössling
Cancers 2021, 13(19), 4947; https://doi.org/10.3390/cancers13194947
Available online: https://www.mdpi.com/2072-6694/13/19/4947

“Exercise and Childhood Cancer—A Historical Review”
by Javier S. Morales, Pedro L. Valenzuela, Daniel Velázquez-Díaz, Adrián Castillo-García, David Jiménez-Pavón, Alejandro Lucia and Carmen Fiuza-Luces
Cancers 2022, 14(1), 82; https://doi.org/10.3390/cancers14010082
Available online: https://www.mdpi.com/2072-6694/14/1/82

“Management of Nutritional Needs in Pediatric Oncology: A Consensus Statement”
by Francesco Fabozzi, Chiara Maria Trovato, Antonella Diamanti, Angela Mastronuzzi, Marco Zecca, Serena Ilaria Tripodi, Riccardo Masetti, Davide Leardini, Edoardo Muratore, Veronica Barat et al.
Cancers 2022, 14(14), 3378; https://doi.org/10.3390/cancers14143378
Available online: https://www.mdpi.com/2072-6694/14/14/3378

“Childhood Malignant Brain Tumors: Balancing the Bench and Bedside”
by Colin Thorbinson and John-Paul Kilday
Cancers 2021, 13(23), 6099; https://doi.org/10.3390/cancers13236099
Available online: https://www.mdpi.com/2072-6694/13/23/6099

“Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation”
by Katharina Weusthof, Peggy Lüttich, Sebastian Regnery, Laila König, Denise Bernhardt, Olaf Witt, Klaus Herfarth, Andreas Unterberg, Christine Jungk, Benjamin Farnia et al.
Cancers 2021, 13(14), 3538; https://doi.org/10.3390/cancers13143538
Available online: https://www.mdpi.com/2072-6694/13/14/3538

“The Role of BiP and the IRE1α–XBP1 Axis in Rhabdomyosarcoma Pathology”
by Mahmoud Aghaei, Ahmad Nasimian, Marveh Rahmati, Philip Kawalec, Filip Machaj, Jakub Rosik, Bhavya Bhushan, S. Zahra Bathaie, Negar Azarpira, Marek J. Los et al.
Cancers 2021, 13(19), 4927; https://doi.org/10.3390/cancers13194927
Available online: https://www.mdpi.com/2072-6694/13/19/4927

“Pursuing Precision: Receptor Tyrosine Kinase Inhibitors for Treatment of Pediatric Solid Tumors”
by Andrew J. Bellantoni and Lars M. Wagner
Cancers 2021, 13(14), 3531; https://doi.org/10.3390/cancers13143531
Available online: https://www.mdpi.com/2072-6694/13/14/3531

“Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth”
by Rameswari Chilamakuri and Saurabh Agarwal
Cancers 2022, 14(4), 1067; https://doi.org/10.3390/cancers14041067
Available online: https://www.mdpi.com/2072-6694/14/4/1067

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office

MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.

In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.

The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.

MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:

To explore more MDPI awards, please click here.

We are pleased to invite you to read the top 10 cited papers in 2020 in Cancers (ISSN: 2072-6694) in the Section "Cancer Drug Development". The paper list is as follows:

1. “Cannabidiol (CBD) as a Promising Anti-Cancer Drug”
by Emily S. Seltzer, Andrea K. Watters, Danny MacKenzie, Jr., Lauren M. Granat and Dong Zhang
Cancers 2020, 12(11), 3203; https://doi.org/10.3390/cancers12113203
Available online: https://www.mdpi.com/2072-6694/12/11/3203

2. “Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines”
by Wei Guo, Hor-Yue Tan, Feiyu Chen, Ning Wang and Yibin Feng
Cancers 2020, 12(2), 404; https://doi.org/10.3390/cancers12020404
Available online: https://www.mdpi.com/2072-6694/12/2/404

3. “Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs”
by Chung-Pu Wu, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Tai-Ho Hung and Yu-Shan Wu
Cancers 2020, 12(1), 195; https://doi.org/10.3390/cancers12010195
Available online: https://www.mdpi.com/2072-6694/12/1/195

4. “Nelfinavir Inhibits the TCF11/Nrf1-Mediated Proteasome Recovery Pathway in Multiple Myeloma”
by Dominika Fassmannová, František Sedlák, Jindřich Sedláček, Ivan Špička and Klára Grantz Šašková
Cancers 2020, 12(5), 1065; https://doi.org/10.3390/cancers12051065
Available online: https://www.mdpi.com/2072-6694/12/5/1065

5. “Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs”
by Chung-Pu Wu, Tai-Ho Hung, Sung-Han Hsiao, Yang-Hui Huang, Lang-Cheng Hung, Yi-Jou Yu, Yu-Tzu Chang, Shun-Ping Wang and Yu-Shan Wu
Cancers 2020, 12(6), 1366; https://doi.org/10.3390/cancers12061366
Available online: https://www.mdpi.com/2072-6694/12/6/1366

6. “Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer”
by Filippos Koinis, Paul Corn, Nila Parikh, Jian Song, Ioulia Vardaki, Ioanna Mourkioti, Sue-Hwa Lin, Christopher Logothetis, Theocharis Panaretakis and Gary Gallick
Cancers 2020, 12(1), 244; https://doi.org/10.3390/cancers12010244
Available online: https://www.mdpi.com/2072-6694/12/1/244

7. “Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1”
by Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Günter Niegisch, Michèle J. Hoffmann, Wolfgang A. Schulz and Matthias U. Kassack
Cancers 2020, 12(2), 337; https://doi.org/10.3390/cancers12020337
Available online: https://www.mdpi.com/2072-6694/12/2/337

8. “Mambalgin-2 Induces Cell Cycle Arrest and Apoptosis in Glioma Cells via Interaction with ASIC1a”
by Maxim Bychkov, Mikhail Shulepko, Dmitry Osmakov, Yaroslav Andreev, Anastasia Sudarikova, Valeria Vasileva, Marat S. Pavlyukov, Yaroslav A. Latyshev, Alexander A. Potapov, Mikhail Kirpichnikov et al.
Cancers 2020, 12(7), 1837; https://doi.org/10.3390/cancers12071837
Available online: https://www.mdpi.com/2072-6694/12/7/1837

9. “Electroporation-Based Treatments in Urology”
by Aleksander Kiełbik, Wojciech Szlasa, Jolanta Saczko and Julita Kulbacka
Cancers 2020, 12(8), 2208; https://doi.org/10.3390/cancers12082208
Available online: https://www.mdpi.com/2072-6694/12/8/2208

10. “L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs”
by Małgorzata Krzystek-Korpacka, Berenika Szczęśniak-Sięga, Izabela Szczuka, Paulina Fortuna, Marek Zawadzki, Agnieszka Kubiak, Magdalena Mierzchała-Pasierb, Mariusz G. Fleszar, Łukasz Lewandowski, Paweł Serek et al.
Cancers 2020, 12(9), 2594; https://doi.org/10.3390/cancers12092594
Available online: https://www.mdpi.com/2072-6694/12/9/2594

For the National Immunization Awareness Month, last August, we shared some high-quality and innovative research findings published in Cancers (ISSN: 2072-6694), which received extensive attention from scholars in this field.

This August, we would continue to share some of the outstanding studies related to cancer immunization published in 2022 and 2023, which are avaliable to read for free.

The list of relevant papers can be seen below:

“Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies”
by Long-Bin Jeng, Li-Ying Liao, Fu-Ying Shih and Chiao-Fang Teng
Cancers 2022, 14(18), 4380; https://doi.org/10.3390/cancers14184380
Available online: https://www.mdpi.com/2072-6694/14/18/4380

“Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy”
by Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Shinji Morisaki, Yusuke Nakamura and Hideya Onishi
Cancers 2022, 14(10), 2438; https://doi.org/10.3390/cancers14102438
Available online: https://www.mdpi.com/2072-6694/14/10/2438

“Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review”
by Xingliang Fang, Huanrong Lan, Ketao Jin, Daojun Gong and Jun Qian
Cancers 2022, 14(16), 3842; https://doi.org/10.3390/cancers14163842
Available online: https://www.mdpi.com/2072-6694/14/16/3842

“Immune Response and Effects of COVID-19 Vaccination in Patients with Lung Cancer—COVID Lung Vaccine Study”
by Ainhoa Hernandez, Marc Boigues, Eudald Felip, Marc Cucurull, Lucia Notario, Anna Pous, Pere Torres, Marta Benitez, Marina Rodriguez, Bibiana Quirant et al.
Cancers 2023, 15(1), 137; https://doi.org/10.3390/cancers15010137
Available online: https://www.mdpi.com/2072-6694/15/1/137

“Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8⁺ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma”
by Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li et al.
Cancers 2022, 14(18), 4512; https://doi.org/10.3390/cancers14184512
Available online: https://www.mdpi.com/2072-6694/14/18/4512

“Safety and Immunogenicity of Combined DNA-Polyethylenimine and Oral Bacterial Idiotypic Vaccine for Patients with B-Cell Non-Hodgkin Lymphoma: A Pilot Study”
by Alexander Meleshko, Nadzeya Piatrouskaya, Katsiaryna Vashkevich, Dzmitry Lutskovich, Chuan Wang, Dmitri Dormeshkin, Natalia Savelyeva and Mikalai Katsin
Cancers 2022, 14(14), 3298; https://doi.org/10.3390/cancers14143298
Available online: https://www.mdpi.com/2072-6694/14/14/3298

“Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster”
by Montserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-Martín, Clara Sánchez-Menéndez, María Aranzazú Murciano-Antón, Javier García-Pérez et al.
Cancers 2022, 14(22), 5537; https://doi.org/10.3390/cancers14225537
Available online: https://www.mdpi.com/2072-6694/14/22/5537

“Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy”
by Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S. Griffith, David Ferguson and Jayanth Panyam
Cancers 2022, 14(24), 6091; https://doi.org/10.3390/cancers14246091
Available online: https://www.mdpi.com/2072-6694/14/24/6091

“Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Melanoma Treated with Immunotherapy”
by Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Aikaterini Gkoufa, Elena Solomou, Amalia Anastasopoulou, Eleni Palli, Panagiotis Kouzis, Spyros Bouros, Mihalis Samarkos, Gkikas Magiorkinis et al.
Cancers 2022, 14(15), 3791; https://doi.org/10.3390/cancers14153791
Available online: https://www.mdpi.com/2072-6694/14/15/3791

“Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma”
by Changwu Wu, Yingjuan Duan, Siming Gong, Georg Osterhoff, Sonja Kallendrusch and Nikolas Schopow
Cancers 2022, 14(2), 448; https://doi.org/10.3390/cancers14020448
Available online: https://www.mdpi.com/2072-6694/14/2/448

MDPI will attend the ASHG Annual Meeting 2023, held in Washington, D.C., USA, from 1 to 5 November 2023.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Biomolecules;
• Medicina;
• Diagnostics;
• Cancers;
• Biomedicines;
• Humans;
• Applied Biosciences;
• DNA;
• IJMS;
• Brain Sciences;
• Cardiogenetics;
• Vaccines;
• Life;
• Epigenomes;
• BioTech;
• Biology;
• CIMB;
• Biomedinformatics.

If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.ashg.org/meetings/.

We are pleased to invite you to read the 2021–2022 selected papers in Cancers (ISSN: 2072-6694) in the Section “Cancer Immunology and Immunotherapy”. The paper list is as follows:

1. “Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy”
by Elayne Irene, Becerra-Báez, Sergio Enrique Meza-Toledo, Paola Muñoz-López, Luis Fernando Flores-Martínez, Karla Fraga-Pérez, Kevin Jorge, Magaño-Bocanegra, Uriel Juárez-Hernández, Armando Alfredo Mateos-Chávez et al.
Cancers 2022, 14(17), 4224; https://doi.org/10.3390/cancers14174224
Available online: https://www.mdpi.com/2072-6694/14/17/4224

2. “Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer”
by Ioannis A. Vathiotis, Tyler MacNeil, Jon Zugazagoitia, Konstantinos N. Syrigos, Thazin Nwe Aung, Aaron M. Gruver, Peter Vaillancourt, Ina Hughes, Steve Hinton, Kyla Driscoll et al.
Cancers 2021, 13(5), 1024; https://doi.org/10.3390/cancers13051024
Available online: https://www.mdpi.com/2072-6694/13/5/1024

3. “Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells”
by Ann-Katrin Menzner, Tanja Rottmar, Simon Voelkl, Jacobus J. Bosch, Dimitrios Mougiakakos, Andreas Mackensen and Yazid J. Resheq
Cancers 2021, 13(3), 461; https://doi.org/10.3390/cancers13030461
Available online: https://www.mdpi.com/2072-6694/13/3/461

4. “Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires”
by Corinna Grunert, Gerald Willimsky, Caroline Anna Peuker, Simone Rhein, Leo Hansmann, Thomas Blankenstein, Eric Blanc, Dieter Beule, Ulrich Keller, Antonio Pezzutto et al.
Cancers 2022, 14(7), 1842; https://doi.org/10.3390/cancers14071842
Available online: https://www.mdpi.com/2072-6694/14/7/1842

5. “Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM”
by Georg Jeryczynski, Arnold Bolomsky, Hermine Agis and Maria-Theresa Krauth
Cancers 2021, 13(23), 5886; https://doi.org/10.3390/cancers13235886
Available online: https://www.mdpi.com/2072-6694/13/23/5886

6. “Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma”
by Samantha Pozzi, Alessia Bari, Martin Pecherstorfer and Sonia Vallet
Cancers 2021, 13(19), 4978; https://doi.org/10.3390/cancers13194978
Available online: https://www.mdpi.com/2072-6694/13/19/4978

7. “Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy”
by Céline Dalmasso, Cécile Pagès, Léonor Chaltiel, Vincent Sibaud, Elisabeth Moyal, Ciprian Chira, Jean Christophe Sol, Igor Latorzeff, Nicolas Meyer and Anouchka Modesto
Cancers 2021, 13(17), 4493; https://doi.org/10.3390/cancers13174493
Available online: https://www.mdpi.com/2072-6694/13/17/4493

8. “Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas”
by Adrian Minson, Constantine Tam, Michael Dickinson and John F. Seymour
Cancers 2022, 14(5), 1276; https://doi.org/10.3390/cancers14051276
Available online: https://www.mdpi.com/2072-6694/14/5/1276

9. “Selective Targeting of Protein Kinase C (PKC)-θ Nuclear Translocation Reduces Mesenchymal Gene Signatures and Reinvigorates Dysfunctional CD8⁺ T Cells in Immunotherapy-Resistant and Metastatic Cancers”
by Jenny Dunn, Robert D. McCuaig, Abel H. Y. Tan, Wen Juan Tu, Fan Wu, Kylie M. Wagstaff, Anjum Zafar, Sayed Ali, Himanshu Diwakar, Jane E. Dahlstrom et al.
Cancers 2022, 14(6), 1596; https://doi.org/10.3390/cancers14061596
Available online: https://www.mdpi.com/2072-6694/14/6/1596

10. “Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article”
by Arthur Bobin, Cécile Gruchet, Stéphanie Guidez, Hélène Gardeney, Laly Nsiala Makunza, Mathilde Vonfeld, Anthony Lévy, Laura Cailly, Florence Sabirou, Thomas Systchenko et al.
Cancers 2021, 13(20), 5210; https://doi.org/10.3390/cancers13205210
Available online: https://www.mdpi.com/2072-6694/13/20/5210

11. “Diet as a Potential Moderator for Genome Stability and Immune Response in Pediatric Leukemia”
by Shanshan Wang, Christopher A. Maxwell and Neha M. Akella
Cancers 2021, 13(3), 413; https://doi.org/10.3390/cancers13030413
Available online: https://www.mdpi.com/2072-6694/13/3/413

12. “Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy”
by Erwan Eriau, Juliette Paillet, Guido Kroemer and Jonathan G. Pol
Cancers 2021, 13(6), 1260; https://doi.org/10.3390/cancers13061260
Available online: https://www.mdpi.com/2072-6694/13/6/1260

13. “Efficacy and Safety of Immunotherapy for Cervical Cancer—A Systematic Review of Clinical Trials”
by Mona W. Schmidt, Marco J. Battista, Marcus Schmidt, Monique Garcia, Timo Siepmann, Annette Hasenburg and Katharina Anic
Cancers 2022, 14(2), 441; https://doi.org/10.3390/cancers14020441
Available online: https://www.mdpi.com/2072-6694/14/2/441

14. “The Potential of T Cell Factor 1 in Sustaining CD8⁺ T Lymphocyte-Directed Anti-Tumor Immunity”
by Sungmin Jung and Jea-Hyun Baek
Cancers 2021, 13(3), 515; https://doi.org/10.3390/cancers13030515
Available online: https://www.mdpi.com/2072-6694/13/3/515

15. “Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review”
by Arman S. Walia, Randy F. Sweis, Piyush K. Agarwal, Andrew K. Kader and Parth K. Modi
Cancers 2022, 14(1), 73; https://doi.org/10.3390/cancers14010073
Available online: https://www.mdpi.com/2072-6694/14/1/73

You can check more information about the Section “Cancer Immunology and Immunotherapy” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Immunology_Immunotherapy.

MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.

We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.

Biomedicines:

• Yuyan Jiang, Stanford University, USA
• Billy Wai-Lung Ng, Chinese University of Hong Kong, China

Cancers:

• Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
• Miranda Fidler-Benaoudia, University of Calgary, Canada

Current Oncology:

• Bishal Gyawali, Queen’s University, Canada

Healthcare:

• Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong

JCM:

• Jan Bednarsch, Universitätsmedizin Berlin, Germany

JPM:

• Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
• Jerome Lechien, University of Mons, Belgium

Pharmaceuticals:

• Daniele Bertoglio, University of Antwerp, Belgium

Pharmaceutics:

• Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

TropicalMed:

• Haley Adcox, Virginia Commonwealth University, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.

For more MDPI awards, please click here.

We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.

MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.

The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.

We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Antibiotics:

• Filip Jansåker, Lund University, Lund, Sweden
• Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal

Cancers:

• Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
• Luigi Russo, Italian Institute of Technology (IIT), Italy

Current Oncology:

• Sneha Sethi, University of Adelaide, Australia
• Xiyin Wang, Indiana University School of Medicine, USA

Dentistry Journal:

• Sonia Nath, University of Adelaide, Australia
• Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania

Diagnostics:

• Adrien Holzgreve, The University Hospital of Munich, Germany

Hemato:

• Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy

JCDD:

• Susanna Cooper, St. George’s University of London, UK
• Renée Tillie, Maastricht University Medical Center, the Netherlands

JCM:

• Max Lennart Eckstein, University of Bayreuth, Germany
• Lorenzo Bertani, University of Pisa, Italy

Pharmaceutics:

• Yuxue Cao, University of Queensland, Australia
• Flávia Sousa, Italian Institute of Technology, Italy

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.

We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.

We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
• Violeta Popovici, Ovidius University of Constanta, Romania
• Yosra A. Helmy, University of Kentucky, USA

Cancers:

• Antonio G. Solimando, Aldo Moro University of Bari, Italy
• Linlin Guo, The Ohio State University Medical Center, USA
• Ravindra Deshpande, Wake Forest School of Medicine, USA
• Songli Zhu, Fred Hutchinson Cancer Research Center, USA
• Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
• Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
• Chenghui Li, University of Arkansas for Medical Sciences, USA
• Laurentiu Pop, University of Texas Southwestern Medical Center, USA
• Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
• Rafał Watrowski, University of Freiburg, Germany
• Ruben C. Petreaca, The Ohio State University, USA
• Ruchi Roy, Rush University Medical Center, USA
• Salvatore Cocuzza, University of Catania, Italy
• Santosh Kumar Singh, Morehouse School of Medicine, USA
• Sergei Boichuk, Kazan State Medical University, Russia
• Simon John Christoph Soerensen, Stanford University, USA
• Takuya Koie, Gifu University, Japan
• Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
• Teruki Nii, Kyushu University, Japan
• Tomasz Marjanski, Medical University of Gdansk, Poland

Current Oncology:

• Kristen Haase, The University of British Columbia, Canada
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Makoto Endo, Kyushu University, Japan

Healthcare:

• Tefera Tadesse, Addis Ababa University, Ethiopia
• Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
• Ryuichi Ohta, Unnan City Hospital, Japan

JCM:

• Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
• José-María Sánchez-González, University of Seville, Spain
• Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece

JPM:

• Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
• Rodolfo Reda, Sapienza University of Rome, Italy
• Giulio Francesco Romiti, Sapienza University of Rome, Italy
• Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
• James Walter, ¹Hines VA Hospital, USA; ² Loyola Medical Center, USA

Medical Sciences:

• Vasiliki Tsigkou, Sotiria Hospital, Greece

Pharmaceutics:

• Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
• Bhupendra Prajapati, Ganpat University, India
• Van-An Duong, Gachon University, Republic of Korea
• Ashish Agrawal, Indian Institute of Technology (BHU), India

Tomography:

• Aydin Eresen, University of California Irvine, USA

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.

We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.

Cancers:

• “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”

by João Pedro da Silva Machado Lobo, University of Porto, Portugal

• “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”

by Adrià Cañellas Socias, University of Barcelona, Spain

Healthcare:

• “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”

by Shireen Mentor, University of Cape Town, South Africa

JPM:

• “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”

by Roberta Magnano San Lio, University of Catania, Italy

Pharmaceutics:

• “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”

by Shirin Tavakoli, University of Helsinki, Finland

TropicalMed:

• “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”

by Quinten Ducarmon, Leiden University Medical Center, the Netherlands

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

For more MDPI awards, please click here.

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.

The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.

We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.

Antibiotics:

• “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
  by Charles H. Chen and Timothy K. Lu
  Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024

• “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
  by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
  Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087

Dentistry Journal:

• “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
  by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
  Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106

• “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
  by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
  Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112

Healthcare:

• “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
  by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
  Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566

• “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
  by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
  Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113

JCM:

• “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
  by Donald J. Alcendor
  J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442

• “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
  by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
  J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417

• “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
  by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
  J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462

JPM:

• “Molecular and Cellular Mechanisms Affected in ALS”
  by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
  J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101

• “Postulated Adjuvant Therapeutic Strategies for COVID-19”
  by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
  J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080

• “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
  by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
  J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179

Pharmaceutics:

• "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
  by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
  Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095

• “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
  by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
  Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002

• “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
  by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
  Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735

Pharmacy:

• “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
  by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
  Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140

• “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
  by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
  Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087

About MDPI Awards:

In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.

See more MDPI awards, please click here.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer epidemiology and prevention. The paper list is as follows:

1. “Is Breast Cancer Risk Associated with Menopausal Hormone Therapy Modified by Current or Early Adulthood BMI or Age of First Pregnancy?”
by Eleni Leventea, Elaine F. Harkness, Adam R. Brentnall, Anthony Howell, D. Gareth Evans and Michelle Harvie
Cancers 2021, 13(11), 2710; https://doi.org/10.3390/cancers13112710
Available online: https://www.mdpi.com/2072-6694/13/11/2710

2. “Epigenetic Drift Association with Cancer Risk and Survival, and Modification by Sex”
by Chenglong Yu, Ee Ming Wong, Jihoon Eric Joo, Allison M. Hodge, Enes Makalic, Daniel Schmidt, Daniel D. Buchanan, Gianluca Severi, John L. Hopper, Dallas R. English et al.
Cancers 2021, 13(8), 1881; https://doi.org/10.3390/cancers13081881
Available online: https://www.mdpi.com/2072-6694/13/8/1881

3. “The Burden of Early-Onset Colorectal Cancer and Its Risk Factors from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019”
by Wan-Jie Gu, Jun-Peng Pei, Jun Lyu, Naohiko Akimoto, Koichiro Haruki, Shuji Ogino and Chun-Dong Zhang
Cancers 2022, 14(14), 3502; https://doi.org/10.3390/cancers14143502
Available online: https://www.mdpi.com/2072-6694/14/14/3502

4. “Risk of Second Primary Malignancies among Patients with Early Gastric Cancer Exposed to Recurrent Computed Tomography Scans”
by Tae Jun Kim, Yeong Chan Lee, Yang Won Min, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Hong-Hee Won, Kyoung Doo Song, Woo Kyoung Jeong and Jae J. Kim
Cancers 2021, 13(5), 1144; https://doi.org/10.3390/cancers13051144
Available online: https://www.mdpi.com/2072-6694/13/5/1144

5. “Demographic and Epidemiological Contributions to Recent Trends in Cancer Incidence in Hong Kong”
by Irene Oi Ling Wong, Yan Ting Lam, Kwok Fai Lam, Benjamin John Cowling and Gabriel Matthew Leung
Cancers 2021, 13(22), 5727; https://doi.org/10.3390/cancers13225727
Available online: https://www.mdpi.com/2072-6694/13/22/5727

6. “Relationship between the Risk of Gastric Cancer and Adherence to the Mediterranean Diet According to Different Estimators. MCC—Spain Study”
by Laura Álvarez-Álvarez, Facundo Vitelli-Storelli, María Rubín-García, Nuria Aragonés, Eva Ardanaz, Gemma Castaño-Vinyals, Mireia Obón-Santacana, Trinidad Dierssen-Sotos, Dolores Salas-Trejo, Adonina Tardón et al.
Cancers 2021, 13(21), 5281; https://doi.org/10.3390/cancers13215281
Available online: https://www.mdpi.com/2072-6694/13/21/5281

7. “Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center”
by Leonardo Micheletti, Fulvio Borella, Mario Preti, Valentina Frau, Stefano Cosma, Sebastiana Privitera, Luca Bertero and Chiara Benedetto
Cancers 2022, 14(1), 124; https://doi.org/10.3390/cancers14010124
Available online: https://www.mdpi.com/2072-6694/14/1/124

8. “Incorporating Robustness to Imaging Physics into Radiomic Feature Selection for Breast Cancer Risk Estimation”
by Raymond J. Acciavatti, Eric A. Cohen, Omid Haji Maghsoudi, Aimilia Gastounioti, Lauren Pantalone, Meng-Kang Hsieh, Emily F. Conant, Christopher G. Scott, Stacey J. Winham, Karla Kerlikowske et al.
Cancers 2021, 13(21), 5497; https://doi.org/10.3390/cancers13215497
Available online: https://www.mdpi.com/2072-6694/13/21/5497

9. “Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future”
by Karla Alfaro, Montserrat Soler, Mauricio Maza, Mauricio Flores, Leticia López, Juan C. Rauda, Andrea Chacón, Patricia Erazo, Nora Villatoro, Eveline Mumenthaler et al.
Cancers 2022, 14(11), 2776; https://doi.org/10.3390/cancers14112776
Available online: https://www.mdpi.com/2072-6694/14/11/2776

10. “Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults”
by In Rae Cho, Sang-Wook Yi, Ja Sung Choi and Jee-Jeon Yi
Cancers 2022, 14(7), 1709; https://doi.org/10.3390/cancers14071709
Available online: https://www.mdpi.com/2072-6694/14/7/1709

11. “Obesity-Independent Association between Glycemic Status and the Risk of Hematologic Malignancy: A Nationwide Population-Based Longitudinal Cohort Study”
by Jihun Kang, Sang-Man Jin, Seok Jin Kim, Dahye Kim, Kyungdo Han, Su-Min Jeong, JiWon Chang, Sang Youl Rhee, Taewoong Choi and Dong Wook Shin
Cancers 2021, 13(19), 4760; https://doi.org/10.3390/cancers13194760
Available online: https://www.mdpi.com/2072-6694/13/19/4760

12. “Impact of Insulin Therapies on Cancer Incidence in Type 1 and Type 2 Diabetes: A Population-Based Cohort Study in Reggio Emilia, Italy”
by Massimo Vicentini, Paola Ballotari, Francesco Venturelli, Marta Ottone, Valeria Manicardi, Marco Gallo, Marina Greci, Mirco Pinotti, Annamaria Pezzarossi and Paolo Giorgi Rossi
Cancers 2022, 14(11), 2719; https://doi.org/10.3390/cancers14112719
Available online: https://www.mdpi.com/2072-6694/14/11/2719

13. “Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients?”
by Dana A. M. Mustafa, Lawlaw Saida, Diba Latifi, Leonoor V. Wismans, Willem de Koning, Lona Zeneyedpour, Theo M. Luider, Bernadette van den Hoogen and Casper H. J. van Eijck
Cancers 2021, 13(12), 2896; https://doi.org/10.3390/cancers13122896
Available online: https://www.mdpi.com/2072-6694/13/12/2896

14. “Pancreatic Tumorigenesis: Oncogenic KRAS and the Vulnerability of the Pancreas to Obesity”
by Yongde Luo, Xiaokun Li, Jianjia Ma, James L. Abbruzzese and Weiqin Lu
Cancers 2021, 13(4), 778; https://doi.org/10.3390/cancers13040778
Available online: https://www.mdpi.com/2072-6694/13/4/778

15. “The Proportion Cured of Patients with Resected Stage II–III Cutaneous Melanoma in Sweden”
by Hanna Eriksson, Deborah Utjés, Roger Olofsson Bagge, Peter Gillgren, Karolin Isaksson, Jan Lapins, Inkeri Leonardsson Schultz, Johan Lyth and Therese M.-L. Andersson
Cancers 2021, 13(10), 2456; https://doi.org/10.3390/cancers13102456
Available online: https://www.mdpi.com/2072-6694/13/10/2456

You can check more information about the Section “Cancer Epidemiology and Prevention” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Epidemiology_Prevention.

MDPI will attend the 29th Annual Meeting of Japan Society of Gene and Cell Therapy. This event will be held at the Osaka International Convention Center for three days from Monday, 11 September, to Wednesday, 13 September 2023.

The theme of this meeting is “Gene Therapy Making a Leap Forward – A Bridge to the Future through Cooperation between Industry, Government and Academia”. Gene and cell therapy has so far been centered on blood diseases, cancers, and metabolic disorders, but gene therapy for spinal muscular atrophy, an intractable neurological disease, was also launched in the US and Japan. Regulations must be well discussed with government agencies, PMDA, and other agencies. The Society will develop a meaningful program to enable sufficient discussions between stakeholders. In addition, a session will be organized by the Scientific Program Committee, a new committee established by the Japan Society of Gene and Cell Therapy.

The following MDPI journals will be represented:

• IJMS;
• CIMB;
• Antioxidants;
• Cancers;
• Current Oncology;
• Metabolites;
• SynBio;
• Biologics;
• Genes;
• Hemato.

If you plan on attending this conference, please feel free to stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.c-linkage.co.jp/jsgct2023/en/index_en.html.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of methods and technologies development. The paper list is as follows:

1. “Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods”
by Shamundeeswari Anandan, Liv Cecilie V. Thomsen, Stein-Erik Gullaksen, Tamim Abdelaal, Katrin Kleinmanns, Jørn Skavland, Geir Bredholt, Bjørn Tore Gjertsen, Emmet McCormack and Line Bjørge
Cancers 2021, 13(4), 755; https://doi.org/10.3390/cancers13040755
Available online: https://www.mdpi.com/2072-6694/13/4/755

2. “3D Model Characterization by 2D and 3D Imaging in t(14;18)-Positive B-NHL: Perspectives for In Vitro Drug Screens in Follicular Lymphoma”
by Fabien Gava, Carla Faria, Pauline Gravelle, Juan G. Valero, Cèlia Dobaño-López, Renaud Morin, Marine Norlund, Aurélie Gomes, Jean-Michel Lagarde, Cédric Rossi et al.
Cancers 2021, 13(7), 1490; https://doi.org/10.3390/cancers13071490
Available online: https://www.mdpi.com/2072-6694/13/7/1490

3. “Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art”
by Malik Galijasevic, Ruth Steiger, Stephanie Mangesius, Julian Mangesius, Johannes Kerschbaumer,
Christian Franz Freyschlag, Nadja Gruber, Tanja Janjic, Elke Ruth Gizewski and Astrid Ellen Grams
Cancers 2022, 14(13), 3197; https://doi.org/10.3390/cancers14133197
Available online: https://www.mdpi.com/2072-6694/14/13/3197

4. “MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer”
by Guillaume Herbreteau, Fabrice Airaud, Elise Pierre-Noël, Audrey Vallée, Stéphane Bézieau, Sandrine Théoleyre, Hélène Blons, Simon Garinet and Marc Guillaume Denis
Cancers 2021, 13(16), 4203; https://doi.org/10.3390/cancers13164203
Available online: https://www.mdpi.com/2072-6694/13/16/4203

5. “Distinct Cerebrovascular Reactivity Patterns for Brain Radiation Necrosis”
by Giovanni Muscas, Christiaan Hendrik Bas van Niftrik, Martina Sebök, Alessandro Della Puppa, Katharina Seystahl, Nicolaus Andratschke, Michelle Brown, Michael Weller, Luca Regli, Marco Piccirelli et al.
Cancers 2021, 13(8), 1840; https://doi.org/10.3390/cancers13081840
Available online: https://www.mdpi.com/2072-6694/13/8/1840

6. “Cell-Main Spectra Profile Screening Technique in Simulation of Circulating Tumour Cells Using MALDI-TOF Mass Spectrometry”
by Wararat Chiangjong, Sebastian Chakrit Bhakdi, Noppawan Woramongkolchai, Thitinee Vanichapol,
Nutkridta Pongsakul, Suradej Hongeng and Somchai Chutipongtanate
Cancers 2021, 13(15), 3775; https://doi.org/10.3390/cancers13153775
Available online: https://www.mdpi.com/2072-6694/13/15/3775

7. “Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo ¹H-Magnetic Resonance Spectroscopy and Machine Learning”
by Elisabeth Bumes, Claudia Fellner, Franz A. Fellner, Karin Fleischanderl, Martina Häckl, Stefan Lenz, Ralf Linker, Tim Mirus, Peter J. Oefner, Christian Paar et al.
Cancers 2022, 14(11), 2762; https://doi.org/10.3390/cancers14112762
Available online: https://www.mdpi.com/2072-6694/14/11/2762

8. “Diagnostic Performance of Ex Vivo Fluorescence Confocal Microscopy in the Assessment of Diagnostic Biopsies of the Prostate”
by Ulf Titze, Torsten Hansen, Christoph Brochhausen, Barbara Titze, Birte Schulz, Alfons Gunnemann,
Bernardo Rocco and Karl-Dietrich Sievert
Cancers 2021, 13(22), 5685; https://doi.org/10.3390/cancers13225685
Available online: https://www.mdpi.com/2072-6694/13/22/5685

9. “Experimental Validation of the MRcollar: An MR Compatible Applicator for Deep Heating in the Head and Neck Region”
by Kemal Sumser, Tomas Drizdal, Gennaro G. Bellizzi, Juan A. Hernandez-Tamames, Gerard C. van Rhoon and Margarethus Marius Paulides
Cancers 2021, 13(22), 5617; https://doi.org/10.3390/cancers13225617
Available online: https://www.mdpi.com/2072-6694/13/22/5617

10. “Inflammatory Microenvironment in Early Non-Small Cell Lung Cancer: Exploring the Predictive Value of Radiomics”
by Mariasole Perrone, Edoardo Raimondi, Matilde Costa, Gianluca Rasetto, Roberto Rizzati, Giovanni Lanza, Roberta Gafà, Giorgio Cavallesco, Nicola Tamburini, Pio Maniscalco et al.
Cancers 2022, 14(14), 3335; https://doi.org/10.3390/cancers14143335
Available online: https://www.mdpi.com/2072-6694/14/14/3335

11. “Unraveling the Structural Variations of Early-Stage Mycosis Fungoides—CD3 Based Purification and Third Generation Sequencing as Novel Tools for the Genomic Landscape in CTCL”
by Carsten Hain, Rudolf Stadler and Jörn Kalinowski
Cancers 2022, 14(18), 4466; https://doi.org/10.3390/cancers14184466
Available online: https://www.mdpi.com/2072-6694/14/18/4466

12. “Comparison of Structural and Short Variants Detected by Linked-Read and Whole-Exome Sequencing in Multiple Myeloma”
by Ashwini Kumar, Sadiksha Adhikari, Matti Kankainen and Caroline A. Heckman
Cancers 2021, 13(6), 1212; https://doi.org/10.3390/cancers13061212
Available online: https://www.mdpi.com/2072-6694/13/6/1212

13. “Tumour Size and T-Stage in Pancreatic Cancer Resection Specimens Depend on the Pathology Examination Approach”
by My Linh Tran, Maia Blomhoff Holm and Caroline Sophie Verbeke
Cancers 2022, 14(10), 2471; https://doi.org/10.3390/cancers14102471
Available online: https://www.mdpi.com/2072-6694/14/10/2471

14. “Biophysical Analysis of Acute and Late Toxicity of Radiotherapy in Gastric Marginal Zone Lymphoma—Impact of Radiation Dose and Planning Target Volume”
by Gabriele Reinartz, Andrea Baehr, Christopher Kittel, Michael Oertel, Uwe Haverkamp and Hans Th. Eich
Cancers 2021, 13(6), 1390; https://doi.org/10.3390/cancers13061390
Available online: https://www.mdpi.com/2072-6694/13/6/1390

15. “Updates on the Management of Acute Myeloid Leukemia”
by Sofía Huerga-Domínguez, Sara Villar, Felipe Prósper and Ana Alfonso-Piérola
Cancers 2022, 14(19), 4756; https://doi.org/10.3390/cancers14194756
Available online: https://www.mdpi.com/2072-6694/14/19/4756

You can check more information about the Section “Methods and Technologies Development” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Methods_Technologies_Development.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer biomarkers. The paper list is as follows:

1. “Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities”
by Lara Paracchini, Maurizio D’Incalci and Sergio Marchini
Cancers 2021, 13(10), 2386; https://doi.org/10.3390/cancers13102386
Available online: https://www.mdpi.com/2072-6694/13/10/2386

2. “Direct Regulation of DNA Repair by E2F and RB in Mammals and Plants: Core Function or Convergent Evolution?”
by Swarnalatha Manickavinayaham, Briana K. Dennehey and David G. Johnson
Cancers 2021, 13(5), 934; https://doi.org/10.3390/cancers13050934
Available online: https://www.mdpi.com/2072-6694/13/5/934

3. “From Immunohistochemistry to New Digital Ecosystems: A State-of-the-Art Biomarker Review for Precision Breast Cancer Medicine”
by Sean M. Hacking, Evgeny Yakirevich and Yihong Wang
Cancers 2022, 14(14), 3469; https://doi.org/10.3390/cancers14143469
Available online: https://www.mdpi.com/2072-6694/14/14/3469

4. “Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups”
by Emilia Bevacqua, Jasmin Farshchi, Maria Victoria Niklison-Chirou and Paola Tucci
Cancers 2021, 13(24), 6323; https://doi.org/10.3390/cancers13246323
Available online: https://www.mdpi.com/2072-6694/13/24/6323

5. “Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model”
by Gloria M. Calaf, Leodan A. Crispin, Debasish Roy, Francisco Aguayo, Juan P. Muñoz and Tammy C. Bleak
Cancers 2021, 13(18), 4571; https://doi.org/10.3390/cancers13184571
Available online: https://www.mdpi.com/2072-6694/13/18/4571

6. “Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer”
by Arkadiusz Gajek, Patrycja Gralewska, Agnieszka Marczak and Aneta Rogalska
Cancers 2021, 13(11), 2690; https://doi.org/10.3390/cancers13112690
Available online: https://www.mdpi.com/2072-6694/13/11/2690

7. “Rationale for Early Detection of EWSR1 Translocation-Associated Sarcoma Biomarkers in Liquid Biopsy”
by Felix I. L. Clanchy
Cancers 2021, 13(4), 824; https://doi.org/10.3390/cancers13040824
Available online: https://www.mdpi.com/2072-6694/13/4/824

8. “Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence”
by Ikuko Kato, Jilei Zhang and Jun Sun
Cancers 2022, 14(2), 425; https://doi.org/10.3390/cancers14020425
Available online: https://www.mdpi.com/2072-6694/14/2/425

9. “Challenges for Better Diagnosis and Management of Pancreatic and Biliary Tract Cancers Focusing on Blood Biomarkers: A Systematic Review”
by Hiroto Tominaga, Juntaro Matsuzaki, Chihiro Oikawa, Kensho Toyoshima, Haruki Manabe, Eriko Ozawa, Atsushi Shimamura, Riko Yokoyama, Yusuke Serizawa, Takahiro Ochiya et al.
Cancers 2021, 13(16), 4220; https://doi.org/10.3390/cancers13164220
Available online: https://www.mdpi.com/2072-6694/13/16/4220

10. “Proteomics as a Complementary Technique to Characterize Bladder Cancer”
by Rubén López-Cortés, Sergio Vázquez-Estévez, Javier Álvarez Fernández and Cristina Núñez
Cancers 2021, 13(21), 5537; https://doi.org/10.3390/cancers13215537
Available online: https://www.mdpi.com/2072-6694/13/21/5537

11. “Genetic Alterations in Adult T-Cell Leukemia/Lymphoma: Novel Discoveries with Clinical and Biological Significance”
by Shugo Sakihama and Kennosuke Karube
Cancers 2022, 14(10), 2394; https://doi.org/10.3390/cancers14102394
Available online: https://www.mdpi.com/2072-6694/14/10/2394

12. “miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine”
by Mara Fernandes, Herlander Marques, Ana Luísa Teixeira and Rui Medeiros
Cancers 2021, 13(24), 6324; https://doi.org/10.3390/cancers13246324
Available online: https://www.mdpi.com/2072-6694/13/24/6324

13. “The Potential and Emerging Role of Quantitative Imaging Biomarkers for Cancer Characterization”
by Hishan Tharmaseelan, Alexander Hertel, Shereen Rennebaum, Dominik Nörenberg, Verena Haselmann, Stefan O. Schoenberg and Matthias F. Froelich
Cancers 2022, 14(14), 3349; https://doi.org/10.3390/cancers14143349
Available online: https://www.mdpi.com/2072-6694/14/14/3349

14. “A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis”
by Peter Shaw, Raghul Senthilnathan, Sunil Krishnan, Deepa Suresh, Sameep Shetty, Gothandam Kodiveri Muthukaliannan, Ravishankar Ram Mani, Palanisamy Sivanandy, Harish Chinna Konda Chandramoorthy, Madan Mohan Gupta et al.
Cancers 2021, 13(17), 4369; https://doi.org/10.3390/cancers13174369
Available online: https://www.mdpi.com/2072-6694/13/17/4369

15. “Familial Risk and Heritability of Hematologic Malignancies in the Nordic Twin Study of Cancer”
by Signe B. Clemmensen, Jennifer R. Harris, Jonas Mengel-From, Wagner H. Bonat, Henrik Frederiksen, Jaakko Kaprio and Jacob v. B. Hjelmborg
Cancers 2021, 13(12), 3023; https://doi.org/10.3390/cancers13123023
Available online: https://www.mdpi.com/2072-6694/13/12/3023

You can check more information about the Section “Cancer Biomarkers” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Biomarkers.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of molecular cancer biology. The paper list is as follows:

1. “Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure”
by Hélène Pasquer, Maëlys Tostain, Nina Kaci, Blandine Roux and Lina Benajiba
Cancers 2021, 13(4), 748; https://doi.org/10.3390/cancers13040748
Available online: https://www.mdpi.com/2072-6694/13/4/748

2. “Tampering of Viruses and Bacteria with Host DNA Repair: Implications for Cellular Transformation”
by Francesca Benedetti, Sabrina Curreli, Robert C. Gallo and Davide Zella
Cancers 2021, 13(2), 241; https://doi.org/10.3390/cancers13020241
Available online: https://www.mdpi.com/2072-6694/13/2/241

3. “DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model”
by Benjamin Lebecque, Céline Bourgne, Véronique Vidal and Marc G. Berger
Cancers 2021, 13(14), 3587; https://doi.org/10.3390/cancers13143587
Available online: https://www.mdpi.com/2072-6694/13/14/3587

4. “Impact of Alternative Splicing Variants on Liver Cancer Biology”
by Jose J. G. Marin, Maria Reviejo, Meraris Soto, Elisa Lozano, Maitane Asensio, Sara Ortiz-Rivero, Carmen Berasain, Matias A. Avila and Elisa Herraez
Cancers 2022, 14(1), 18; https://doi.org/10.3390/cancers14010018
Available online: https://www.mdpi.com/2072-6694/14/1/18

5. “Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian Cancer”
by Sweta Sharma Saha, Lucy Gentles, Alice Bradbury, Dominik Brecht, Rebecca Robinson, Rachel O’Donnell, Nicola J. Curtin and Yvette Drew
Cancers 2021, 13(6), 1420; https://doi.org/10.3390/cancers13061420
Available online: https://www.mdpi.com/2072-6694/13/6/1420

6. “NTRK1/TrkA Signaling in Neuroblastoma Cells Induces Nuclear Reorganization and Intra-Nuclear Aggregation of Lamin A/C”
by Lukas Funke, Thilo Bracht, Sebastian Oeck, Karin Schork, Markus Stepath, Sabine Dreesmann, Martin Eisenacher, Barbara Sitek and Alexander Schramm
Cancers 2021, 13(21), 5293; https://doi.org/10.3390/cancers13215293
Available online: https://www.mdpi.com/2072-6694/13/21/5293

7. “p300 Serine 89: A Critical Signaling Integrator and Its Effects on Intestinal Homeostasis and Repair?”
by Keane K. Y. Lai, Xiaohui Hu, Keisuke Chosa, Cu Nguyen, David P. Lin, Keith K. Lai, Nobuo Kato, Yusuke Higuchi, Sarah K. Highlander, Elizabeth Melendez et al.
Cancers 2021, 13(6), 1228; https://doi.org/10.3390/cancers13061288
Available online: https://www.mdpi.com/2072-6694/13/6/1288

8. “Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review”
by Giulia Corrao, Mattia Zaffaroni, Luca Bergamaschi, Matteo Augugliaro, Stefania Volpe, Matteo Pepa, Giuseppina Bonizzi, Salvatore Pece, Nicola Amodio, Francesco Alessandro Mistretta et al.
Cancers 2021, 13(13), 3278; https://doi.org/10.3390/cancers13133278
Available online: https://www.mdpi.com/2072-6694/13/13/3278

9. “The Cellular and Biological Impact of Extracellular Vesicles in Pancreatic Cancer”
by Zainab Hussain, Jeremy Nigri and Richard Tomasini
Cancers 2021, 13(12), 3040; https://doi.org/10.3390/cancers13123040
Available online: https://www.mdpi.com/2072-6694/13/12/3040

10. “The Role of Circular RNAs in Keratinocyte Carcinomas”
by Thomas Meyer, Michael Sand, Lutz Schmitz and Eggert Stockfleth
Cancers 2021, 13(16), 4240; https://doi.org/10.3390/cancers13164240
Available online: https://www.mdpi.com/2072-6694/13/16/4240

11. “MAPK Inhibition Requires Active RAC1 Signaling to Effectively Improve Iodide Uptake by Thyroid Follicular Cells”
by Márcia Faria, Rita Domingues, Maria João Bugalho, Paulo Matos and Ana Luísa Silva
Cancers 2021, 13(22), 5861; https://doi.org/10.3390/cancers13225861
Available online: https://www.mdpi.com/2072-6694/13/22/5861

12. “The Role of Fast-Cycling Atypical RHO GTPases in Cancer”
by Pontus Aspenström
Cancers 2022, 14(8), 1961; https://doi.org/10.3390/cancers14081961
Available online: https://www.mdpi.com/2072-6694/14/8/1961

13. “MicroRNA Profile Alterations in Parathyroid Carcinoma: Latest Updates and Perspectives”
by Marta Wielogórska, Beata Podgórska, Magdalena Niemira, Małgorzata Szelachowska, Adam Krętowski and Katarzyna Siewko
Cancers 2022, 14(4), 876; https://doi.org/10.3390/cancers14040876
Available online: https://www.mdpi.com/2072-6694/14/4/876

14. “MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes”
by Cyril Sobolewski, Laurent Dubuquoy and Noémie Legrand
Cancers 2022, 14(14), 3516; https://doi.org/10.3390/cancers14143516
Available online: https://www.mdpi.com/2072-6694/14/14/3516

15. “Analysis of Genomic Alterations Associated with Recurrence in Early Stage HER2-Positive Breast Cancer”
by Yong-Seok Kim, Der Sheng Sun, Juneyoung Ahn, Yongseon Kim, Jung-Sook Yoon and Hye Sung Won
Cancers 2022, 14(15), 3650; https://doi.org/10.3390/cancers14153650
Available online: https://www.mdpi.com/2072-6694/14/15/3650

You can check more information about the Section “Molecular Cancer Biology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Molecular_Cancer_Biology.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer metastasis. The paper list is as follows:

1. “TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patient”
by Ritu Pandey, Nathan Johnson, Laurence Cooke, Benny Johnson, Yuliang Chen, Manjari Pandey, Jason Chandler and Daruka Mahadevan
Cancers 2021, 13(4), 597; https://doi.org/10.3390/cancers13040597
Available online: https://www.mdpi.com/2072-6694/13/4/597

2. “Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates”
by Hee Yeon Lee and In Sook Woo
Cancers 2021, 13(18), 4590; https://doi.org/10.3390/cancers13184590
Available online: https://www.mdpi.com/2072-6694/13/18/4590

3. “GPR87 Promotes Metastasis through the AKT-eNOS-NO Axis in Lung Adenocarcinoma”
by Hye-Mi Ahn, Eun-Young Choi and Youn-Jae Kim
Cancers 2022, 14(1), 19; https://doi.org/10.3390/cancers14010019
Available online: https://www.mdpi.com/2072-6694/14/1/19

4. “Machine Learning Model to Stratify the Risk of Lymph Node Metastasis for Early Gastric Cancer: A Single-Center Cohort Study”
by Ji-Eun Na, Yeong-Chan Lee, Tae-Jun Kim Hyuk Lee, Hong-Hee Won, Yang-Won Min, Byung-Hoon Min, Jun-Haeng Lee, Poong-Lyul Rhee and Jae J. Kim
Cancers 2022, 14(5), 1121; https://doi.org/10.3390/cancers14051121
Available online: https://www.mdpi.com/2072-6694/14/5/1121

5. “Salmonella Impacts Tumor-Induced Macrophage Polarization, and Inhibits SNAI1-Mediated Metastasis in Melanoma”
by Christian R. Pangilinan, Li-Hsien Wu and Che-Hsin Lee
Cancers 2021, 13(12), 2894; https://doi.org/10.3390/cancers13122894
Available online: https://www.mdpi.com/2072-6694/13/12/2894

6. “Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis”
by Alexandra Q. Bartlett, Nathan D. Pennock, Alex Klug and Pepper Schedin
Cancers 2021, 13(7), 1698; https://doi.org/10.3390/cancers13071698
Available online: https://www.mdpi.com/2072-6694/13/7/1698

7. “HIF-Dependent CKB Expression Promotes Breast Cancer Metastasis, Whereas Cyclocreatine Therapy Impairs Cellular Invasion and Improves Chemotherapy Efficacy”
by Raisa I. Krutilina, Hilaire Playa, Danielle L. Brooks, Luciana P. Schwab, Deanna N. Parke, Damilola Oluwalana, Douglas R. Layman, Meiyun Fan, Daniel L. Johnson, Junming Yue et al.
Cancers 2022, 14(1), 27; https://doi.org/10.3390/cancers14010027
Available online: https://www.mdpi.com/2072-6694/14/1/27

8. “Canonical NF-κB Promotes Lung Epithelial Cell Tumour Growth by Downregulating the Metastasis Suppressor CD82 and Enhancing Epithelial-to-Mesenchymal Cell Transition”
by Eugenia Roupakia, Evangelia Chavdoula, Georgia Karpathiou, Giannis Vatsellas, Dimitrios Chatzopoulos, Angeliki Mela, Jennifer M. Gillette, Katharina Kriegsmann, Mark Kriegsmann, Anna Batistatou et al.
Cancers 2021, 13(17), 4302; https://doi.org/10.3390/cancers13174302
Available online: hhttps://www.mdpi.com/2072-6694/13/17/4302

9. “Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies”
by Marta Jaén, Rubén A. Bartolomé, Carmen Aizpurua, Ángela Martin-Regalado, J. Ignacio Imbaud and J. Ignacio Casal
Cancers 2021, 13(7), 1731; https://doi.org/10.3390/cancers13071731
Available online: https://www.mdpi.com/2072-6694/13/7/1731

10. “A Highly Reliable Convolutional Neural Network Based Soft Tissue Sarcoma Metastasis Detection from Chest X-ray Images: A Retrospective Cohort Study”
by Christoph Wallner, Mansoor Alam, Marius Drysch, Johannes Maximilian Wagner, Alexander Sogorski, Mehran Dadras, Maxi von Glinski, Felix Reinkemeier, Mustafa Becerikli, Christoph Heute et al.
Cancers 2021, 13(19), 4961; https://doi.org/10.3390/cancers13194961
Available online: https://www.mdpi.com/2072-6694/13/19/4961

11. “SIPA1 Is a Modulator of HGF/MET Induced Tumour Metastasis via the Regulation of Tight Junction-Based Cell to Cell Barrier Function”
by Chang Liu, Wenguo Jiang, Lijian Zhang, Rachel Hargest and Tracey A. Martin
Cancers 2021, 13(7), 1747; https://doi.org/10.3390/cancers13071747
Available online: https://www.mdpi.com/2072-6694/13/7/1747

12. “Differential Expression of BOC, SPOCK2, and GJD3 Is Associated with Brain Metastasis of ER-Negative Breast Cancers”
by Rute M. S. M. Pedrosa, Leonoor V. Wismans, Renata Sinke, Marcel van der Weiden, Casper H. J. van Eijck, Johan M. Kros and Dana A. M. Mustafa
Cancers 2021, 13(12), 2982; https://doi.org/10.3390/cancers13122982
Available online: https://www.mdpi.com/2072-6694/13/12/2982

13. “Obesity-Activated Lung Stromal Cells Promote Myeloid Lineage Cell Accumulation and Breast Cancer Metastasis”
by Lauren E. Hillers-Ziemer, Abbey E. Williams, Amanda Janquart, Caitlin Grogan, Victoria Thompson, Adriana Sanchez and Lisa M. Arendt
Cancers 2021, 13(5), 1005; https://doi.org/10.3390/cancers13051005
Available online: https://www.mdpi.com/2072-6694/13/5/1005

14. “Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up”
by Jörg Tamihardja, Leonie Zehner, Philipp Hartrampf, Dominik Lisowski, Susanne Kneitz, Sinan Cirsi, Gary Razinskas, Michael Flentje and Bülent Pola
Cancers 2022, 14(15), 3766; https://doi.org/10.3390/cancers14153766
Available online: https://www.mdpi.com/2072-6694/14/15/3766

15. “Orai3 Regulates Pancreatic Cancer Metastasis by Encoding a Functional Store Operated Calcium Entry Channel”
by Samriddhi Arora, Jyoti Tanwar, Nutan Sharma, Suman Saurav and Rajender K. Motian
Cancers 2021, 13(23), 5937; https://doi.org/10.3390/cancers13235937
Available online: https://www.mdpi.com/2072-6694/13/23/5937

You can check more information about the Section “Cancer Metastasis” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Metastasis.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of clinical trials of cancer. The paper list is as follows:

1. “Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-analysis of Phase III Clinical Trials”
by Laercio Lopes da Silva, Pedro Nazareth Aguiar, Jr., Robin Park, Eduardo Edelman Saul, Benjamin Haaland and Gilberto de Lima Lopes
Cancers 2021, 13(11), 2614; https://doi.org/10.3390/cancers13112614
Available online: https://www.mdpi.com/2072-6694/13/11/2614

2. “The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma”
by David R. Ghasemi, Gudrun Fleischhack, Till Milde and Kristian W. Pajtler
Cancers 2022, 14(3), 679; https://doi.org/10.3390/cancers14030679
Available online: https://www.mdpi.com/2072-6694/14/3/679

3. “The Clinical and Pathological Profile of BRCA1 Gene Methylated Breast Cancer Women: A Meta-Analysis”
by Ilary Ruscito, Maria Luisa Gasparri, Maria Paola De Marco, Flavia Costanzi, Aris Raad Besharat, Andrea Papadia, Thorsten Kuehn, Oreste Davide Gentilini, Filippo Bellati and Donatella Caserta
Cancers 2021, 13(6), 1391; https://doi.org/10.3390/cancers13061391
Available online: https://www.mdpi.com/2072-6694/13/6/1391

4. “Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia”
by Axel H. Schönthal, Steve Swenson, Radu O. Minea, Hye Na Kim, Heeyeon Cho, Nazleen Mohseni, Yong-Mi Kim and Thomas C. Chen
Cancers 2021, 13(14), 3385; https://doi.org/10.3390/cancers13143385
Available online: https://www.mdpi.com/2072-6694/13/14/3385

5. “Development of Randomized Trials in Adults with Medulloblastoma—The Example of EORTC 1634-BTG/NOA-23”
by Peter Hau, Didier Frappaz, Elizabeth Hovey, Martin G. McCabe, Kristian W. Pajtler, Benedikt Wiestler, Clemens Seidel, Stephanie E. Combs, Linda Dirven, Martin Klein et al.
Cancers 2021, 13(14), 3451; https://doi.org/10.3390/cancers13143451
Available online: https://www.mdpi.com/2072-6694/13/14/3451

6. “Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial”
by Renaud Sabatier, Jean-Yves Pierga, Hervé Curé, Rakan Abulnaja, Eric Lambaudie, François-Clément Bidard, Jean-Marc Extra, Patrick Sfumato and Anthony Gonçalves
Cancers 2021, 13(1), 140; https://doi.org/10.3390/cancers13010140
Available online: https://www.mdpi.com/2072-6694/13/1/140

7. “New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas”
by Cristina Porcheri and Thimios A. Mitsiadis
Cancers 2021, 13(21), 5515; https://doi.org/10.3390/cancers13215515
Available online: https://www.mdpi.com/2072-6694/13/21/5515

8. “A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX”
by Charlotte I. Stroes, Sandor Schokker, Remco J. Molenaar, Ron A. A. Mathôt, Maarten F. Bijlsma, Stephanie O. van der Woude, João P. Belo Pereira, Gerrit K. J. Hooijer, Rob H. A. Verhoeven, Annemieke Cats et al.
Cancers 2021, 13(4), 839; https://doi.org/10.3390/cancers13040839
Available online: https://www.mdpi.com/2072-6694/13/4/839

9. “Cardiovascular Toxicities Secondary to Biotherapy and Molecular Targeted Therapies in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials”
by Charalampos Aktypis, Maria-Eleni Spei, Maria Yavropoulou, Göran Wallin, Anna Koumarianou, Gregory Kaltsas, Eva Kassi and Kosmas Daskalakis
Cancers 2021, 13(9), 2159; https://doi.org/10.3390/cancers13092159
Available online: https://www.mdpi.com/2072-6694/13/9/2159

10. “Dramatic Reduction of Distant Pancreatic Metastases Using Local Light Activation of Verteporfin with Nab-Paclitaxel”
by Michael Pigula, Zhiming Mai, Sriram Anbil, Myung-Gyu Choi, Kenneth Wang, Edward Maytin, Brian Pogue and Tayyaba Hasan
Cancers 2021, 13(22), 5781; https://doi.org/10.3390/cancers13225781
Available online: https://www.mdpi.com/2072-6694/13/22/5781

11. “Long-Term Treatment with Bortezomib Induces Specific Methylation Changes in Differentiated Neuronal Cells”
by Karolina Łuczkowska, Olga Taryma-Leśniak, Jan Bińkowski, Katarzyna E. Sokołowska, Dominik Strapagiel, Justyna Jarczak, Edyta Paczkowska, Bogusław Machaliński and Tomasz K. Wojdacz
Cancers 2022, 14(14), 3402; https://doi.org/10.3390/cancers14143402
Available online: https://www.mdpi.com/2072-6694/14/14/3402

12. “Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia”
by Javier Bregante, Anna Schönbichler, Daniel Pölöske, Lina Degenfeld-Schonburg, Garazi Monzó Contreras, Emir Hadzijusufovic, Elvin D. de Araujo, Peter Valent, Richard Moriggl and Anna Orlova
Cancers 2021, 13(24), 6181; https://doi.org/10.3390/cancers13246181
Available online: https://www.mdpi.com/2072-6694/13/24/6181

13. “Oncogene-Induced Reprogramming in Acute Lymphoblastic Leukemia: Towards Targeted Therapy of Leukemia-Initiating Cells”
by Vincent Fregona, Manon Bayet and Bastien Gerby
Cancers 2021, 13(21), 5511; https://doi.org/10.3390/cancers13215511
Available online: https://www.mdpi.com/2072-6694/13/21/5511

14. “Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future”
by Walid Shalata, Binil Mathew Jacob and Abed Agbarya
Cancers 2021, 13(16), 4119; https://doi.org/10.3390/cancers13164119
Available online: https://www.mdpi.com/2072-6694/13/16/4119

15. “Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?”
by Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini and Alba Ariela Brandes
Cancers 2022, 14(2), 333; https://doi.org/10.3390/cancers14020333
Available online: https://www.mdpi.com/2072-6694/14/2/333

You can check more information about the Section “Clinical Trials of Cancer” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Clinical_Trials_Cancer.

To commemorate the World Hepatitis Day 2023, MDPI organized a webinar on 28 July 2023 to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis. The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030.

Session 1:

 You can watch the recorded webinar below:

Session 2:

 You can watch the recorded webinar below:

 Relevant Special Issues:

Pathogens
“Research on Hepatitis B Virus: Past, Present, and Future”
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
“Novel Challenges and Therapeutic Options for Liver Diseases”
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
“Viral Hepatitis Research: Updates and Challenges”
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
“Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States”
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
“Diagnosis and Management of Liver Diseases—2nd Edition”
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
“Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives”
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer therapy. The paper list is as follows:

1. “CAR T-Cells for CNS Lymphoma: Driving into New Terrain?”
by Philipp Karschnia, Jens Blobner, Nico Teske, Florian Schöberl, Esther Fitzinger, Martin Dreyling, Joerg-Christian Tonn, Niklas Thon, Marion Subklewe and Louisa von Baumgarten
Cancers 2021, 13(10), 2503; https://doi.org/10.3390/cancers13102503
Available online: https://www.mdpi.com/2072-6694/13/10/2503

2. “Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?”
by Marco Mazzotta, Laura Pizzuti, Eriseld Krasniqi, Francesca Sofia Di Lisa, Federico Cappuzzo, Lorenza Landi, Domenico Sergi, Fabio Pelle, Sonia Cappelli, Claudio Botti et al.
Cancers 2021, 13(16), 4061; https://doi.org/10.3390/cancers13164061
Available online: https://www.mdpi.com/2072-6694/13/16/4061

3. “Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer”
by Elisabeth Smolle, Valentin Taucher, Joerg Lindenmann, Philipp J. Jost and Martin Pichler
Cancers 2021, 13(4), 699; https://doi.org/10.3390/cancers13040699
Available online: https://www.mdpi.com/2072-6694/13/4/699

4. “Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments”
by Simona Pagliuca, Carmelo Gurnari and Valeria Visconte
Cancers 2022, 13(4), 784; https://doi.org/10.3390/cancers13040784
Available online: https://www.mdpi.com/2072-6694/13/4/784

5. “Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum”
by Jemina Lehto, Anna Huguet Ninou, Dimitrios Chioureas, Jos Jonkers and Nina M. S. Gustafsson
Cancers 2021, 13(6), 1442; https://doi.org/10.3390/cancers13061442
Available online: https://www.mdpi.com/2072-6694/13/6/1442

6. “The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond”
by Irene Strassl, Martin Schreder, Normann Steiner, Jakob Rudzki, Hermine Agis, Tina Künz, Nino Müser, Wolfgang Willenbacher, Andreas Petzer, Peter Neumeister et al.
Cancers 2021, 13(18), 4701; https://doi.org/10.3390/cancers13184701
Available online: https://www.mdpi.com/2072-6694/13/18/4701

7. “Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome”
by Asima Abidi, Mark A. J. Gorris, Evan Brennan, Marjolijn C. J. Jongmans, Dilys D. Weijers, Roland P. Kuiper, Richarda M. de Voer, Nicoline Hoogerbrugge, Gerty Schreibelt and I. Jolanda M. de Vries
Cancers 2021, 13(10), 2345; https://doi.org/10.3390/cancers13102345
Available online: https://www.mdpi.com/2072-6694/13/10/2345

8. “Regulations, Open Data and Healthcare Innovation: A Case of MSK-IMPACT and Its Implications for Better Cancer Care”
by Takaharu Jibiki, Hayato Nishimura, Shintaro Sengoku and Kota Kodama
Cancers 2021, 13(14), 3448; https://doi.org/10.3390/cancers13143448
Available online: https://www.mdpi.com/2072-6694/13/14/3448

9. “Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine”
by Ioannis Chanias, Kristina Stojkov, Gregor Th. Stehle, Michael Daskalakis, Helena Simeunovic, Linet Muthoni Njue, Annatina S. Schnegg-Kaufmann, Naomi A. Porret, Ramanjaneyulu Allam, Tata Nageswara Rao et al.
Cancers 2021, 13(13), 3296; https://doi.org/10.3390/cancers13133296
Available online: https://www.mdpi.com/2072-6694/13/13/3296

10. “Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (¹¹¹In)/Yttrium 90 (⁹⁰Y) Ibritumomab Tiuxetan (Zevalin^®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels”
by Richard L. Wahl, Eric C. Frey, Heather A. Jacene, Brad S. Kahl, Steven Piantadosi, Jesus A. Bianco, Richard J. Hammes, Miah Jung, Wayne Kasecamp, Bin He et al.
Cancers 2021, 13(11), 2828; https://doi.org/10.3390/cancers13112828
Available online: https://www.mdpi.com/2072-6694/13/11/2828

11. “Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver Disease”
by Chaobo Chen, Hanghang Wu, Hui Ye, Agustín Tortajada, Sandra Rodríguez-Perales, Raúl Torres-Ruiz, August Vidal, Maria Isabel Peligros, Johanna Reissing, Tony Bruns et al.
Cancers 2022, 14(1), 78; https://doi.org/10.3390/cancers14010078
Available online: https://www.mdpi.com/2072-6694/14/1/78

12. “Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer”
by Paola Anna Jablonska, Joaquim Bosch-Barrera, Diego Serrano, Manuel Valiente, Alfonso Calvo and Javier Aristu
Cancers 2021, 13(9), 2141; https://doi.org/10.3390/cancers13092141
Available online: https://www.mdpi.com/2072-6694/13/9/2141

13. “Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer”
by Arturo Araujo, Leah M. Cook, Jeremy S. Frieling, Winston Tan, John A. Copland II, Manish Kohli, Shilpa Gupta, Jasreman Dhillon, Julio Pow-Sang, Conor C. Lynch et al.
Cancers 2021, 13(14), 677; https://doi.org/10.3390/cancers13040677
Available online: https://www.mdpi.com/2072-6694/13/4/677

14. “Gliomas Infiltrating the Corpus Callosum: A Systematic Review of the Literature”
by Paolo Palmisciano, Gianluca Ferini, Gina Watanabe, Christian Ogasawara, Emal Lesha, Othman Bin-Alamer, Giuseppe E. Umana, Kenny Yu, Aaron A. Cohen-Gadol, Tarek Y. El Ahmadieh et al.
Cancers 2022, 14(10), 2507; https://doi.org/10.3390/cancers14102507
Available online: https://www.mdpi.com/2072-6694/14/10/2507

15. “Defining the Criteria for Reflex Testing for BRAF Mutations in Cutaneous Melanoma Patients”
by Sarah Zhou, Daniel Sikorski, Honghao Xu, Andrei Zubarev, May Chergui, François Lagacé, Wilson H. Miller, Jr., Margaret Redpath, Stephanie Ghazal, Marcus O. Butler et al.
Cancers 2021, 13(9), 2282; https://doi.org/10.3390/cancers13092282
Available online: https://www.mdpi.com/2072-6694/13/9/2282

You can check more information about the Section “Cancer Therapy” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Therapy.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) in the Section “Cancer Informatics and Big Data”. The paper list is as follows:

1. “The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis”
by Jacek Marzec, Helen Ross-Adams, Stefano Pirrò, Jun Wang, Yanan Zhu, Xueying Mao, Emanuela Gadaleta, Amar S. Ahmad, Bernard V. North, Solène-Florence Kammerer-Jacquet et al.
Cancers 2021, 13(2), 345; https://doi.org/10.3390/cancers13020345
Available online: https://www.mdpi.com/2072-6694/13/2/345

2. “Bioinformatic Approaches to Validation and Functional Analysis of 3D Lung Cancer Models”
by P. Jonathan Li, Jeroen P. Roose, David M. Jablons and Johannes R. Kratz
Cancers 2021, 13(4), 701; https://doi.org/10.3390/cancers13040701
Available online: https://www.mdpi.com/2072-6694/13/4/701

3. “Cancers in Agreement? Exploring the Cross-Talk of Cancer Metabolomic and Transcriptomic Landscapes Using Publicly Available Data”
by Derek van Tilborg and Edoardo Saccenti
Cancers 2021, 13(3), 393; https://doi.org/10.3390/cancers13030393
Available online: https://www.mdpi.com/2072-6694/13/3/393

4. “Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers”
by Peng-Chan Lin, Yu-Min Yeh, Hui-Ping Hsu, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Keng-Fu Hsu, Jenn-Ren Hsiao, Yan-Shen Shan et al.
Cancers 2021, 13(17), 4317; https://doi.org/10.3390/cancers13174317
Available online: https://www.mdpi.com/2072-6694/13/17/4317

5. “Epigenomic Analysis of RAD51 ChIP-seq Data Reveals cis-regulatory Elements Associated with Autophagy in Cancer Cell Lines”
by Keunsoo Kang, Yoonjung Choi, Hyeonjin Moon, Chaelin You, Minjin Seo, Geunho Kwon, Jahyun Yun, Boram Beck and Kyuho Kang
Cancers 2021, 13(11), 2547; https://doi.org/10.3390/cancers13112547
Available online: https://www.mdpi.com/2072-6694/13/11/2547

6. “Identifying Cancer Drivers Using DRIVE: A Feature-Based Machine Learning Model for a Pan-Cancer Assessment of Somatic Missense Mutations”
by Ionut Dragomir, Adnan Akbar, John W. Cassidy, Nirmesh Patel, Harry W. Clifford and Gianmarco Contino
Cancers 2021, 13(11), 2779; https://doi.org/10.3390/cancers13112779
Available online: https://www.mdpi.com/2072-6694/13/11/2779

7. “SurvCNN: A Discrete Time-to-Event Cancer Survival Estimation Framework Using Image Representations of Omics Data”
by Yogesh Kalakoti, Shashank Yadav and Durai Sundar
Cancers 2021, 13(13), 3106; https://doi.org/10.3390/cancers13133106
Available online: https://www.mdpi.com/2072-6694/13/13/3106

8. “Gene-Mutation-Based Algorithm for Prediction of Treatment Response in Colorectal Cancer Patients”
by Heather Johnson, Zahra El-Schich, Amjad Ali, Xuhui Zhang, Athanasios Simoulis, Anette Gjörloff Wingren and Jenny L. Persson
Cancers 2022, 14(8), 2045; https://doi.org/10.3390/cancers14082045
Available online: https://www.mdpi.com/2072-6694/14/8/2045

9. “Discovering Digital Tumor Signatures—Using Latent Code Representations to Manipulate and Classify Liver Lesions”
by Jens Kleesiek, Benedikt Kersjes, Kai Ueltzhöffer, Jacob M. Murray, Carsten Rother, Ullrich Köthe and Heinz-Peter Schlemmer
Cancers 2021, 13(13), 3108; https://doi.org/10.3390/cancers13133108
Available online: https://www.mdpi.com/2072-6694/13/13/3108

10. “Predicting Postoperative Complications in Cancer Patients: A Survey Bridging Classical and Machine Learning Contributions to Postsurgical Risk Analysis”
by Gonçalves, Daniel M., Rui Henriques and Rafael S. Costa
Cancers 2021, 13(13), 3217; https://doi.org/10.3390/cancers13133217
Available online: https://www.mdpi.com/2072-6694/13/13/3217

11. “Survival-Critical Genes Associated with Copy Number Alterations in Lung Adenocarcinoma”
by Chinthalapally V. Rao, Chao Xu, Mudassir Farooqui, Yuting Zhang, Adam S. Asch and Hiroshi Y. Yamada
Cancers 2021, 13(11), 2586; https://doi.org/10.3390/cancers13112586
Available online: https://www.mdpi.com/2072-6694/13/11/2586

12. “PPAR-Responsive Elements Enriched with Alu Repeats May Contribute to Distinctive PPARγ–DNMT1 Interactions in the Genome”
by Sharma Amit, Fabian Tobar-Tosse, Tikam Chand Dakal, Hongde Liu, Arijit Biswas, Athira Menon, Anoosha Paruchuri, Panagiotis Katsonis, Olivier Lichtarge, M. Michael Gromiha et al.
Cancers 2021, 13(16), 3993; https://doi.org/10.3390/cancers13163993
Available online: https://www.mdpi.com/2072-6694/13/16/3993

13. “Network-Based Analysis to Identify Drivers of Metastatic Prostate Cancer Using GoNetic”
by Louise de Schaetzen van Brienen, Giles Miclotte, Maarten Larmuseau, Jimmy Van den Eynden and Kathleen Marchal
Cancers 2021, 13(21), 5291; https://doi.org/10.3390/cancers13215291
Available online: https://www.mdpi.com/2072-6694/13/21/5291

14. “Network-Based Integration of Multi-Omics Data Identifies the Determinants of miR-491-5p Effects”
by Matthieu Meryet-Figuiere, Mégane Vernon, Mamy Andrianteranagna, Bernard Lambert, Célia Brochen, Jean-Paul Issartel, Audrey Guttin, Pascal Gauduchon, Emilie Brotin, Florent Dingli et al.
Cancers 2021, 13(16), 3970; https://doi.org/10.3390/cancers13163970
Available online: https://www.mdpi.com/2072-6694/13/16/3970

15. “Prediction of Incident Cancers in the Lifelines Population-Based Cohort”
by Francisco O. Cortés-Ibañez, Sunil Belur Nagaraj, Ludo Cornelissen, Gerjan J. Navis, Bert van der Vegt, Grigory Sidorenkov and Geertruida H. de Bock
Cancers 2021, 13(9), 2133; https://doi.org/10.3390/cancers13092133
Available online: https://www.mdpi.com/2072-6694/13/9/2133

You can check more information about the Section “Cancer Informatics and Big Data” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Informatics_Big_Data.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer pathophysiology. The paper list is as follows:

1. “The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis”
by Yuh Cai Chia, Md Asiful Islam, Phil Hider, Peng Yeong Woon, Muhammad Farid Johan, Rosline Hassan and Marini Ramli
Cancers 2021, 13(12), 3078; https://doi.org/10.3390/cancers13123078
Available online: https://www.mdpi.com/2072-6694/13/12/3078

2. “Recent Advances in Implantation-Based Genetic Modeling of Biliary Carcinogenesis in Mice”
by Masashi Izumiya, Shingo Kato and Yoshitaka Hippo
Cancers 2021, 13(10), 2292; https://doi.org/10.3390/cancers13102292
Available online: https://www.mdpi.com/2072-6694/13/10/2292

3. “ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers”
by Albina Fejza, Lucrezia Camicia, Evelina Poletto, Greta Carobolante, Maurizio Mongiat and Eva Andreuzzi
Cancers 2021, 13(11), 2759; https://doi.org/10.3390/cancers13112759
Available online: https://www.mdpi.com/2072-6694/13/11/2759

4. “Pathological Changes in Pancreatic Carcinogenesis: A Review”
by Keiko Yamakawa, Juanjuan Ye, Yuko Nakano-Narusawa and Yoko Matsuda
Cancers 2021, 13(4), 686; https://doi.org/10.3390/cancers13040686
Available online: https://www.mdpi.com/2072-6694/13/4/686

5. “Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma”
by Federica Ragusa, Nadia Panera, Silvia Cardarelli, Marco Scarsella, Marzia Bianchi, Stefano Biagioni, Mauro Giorgi, Anna Alisi and Mara Massimi
Cancers 2021, 13(9), 2182; https://doi.org/10.3390/cancers13092182
Available online: https://www.mdpi.com/2072-6694/13/9/2182

6. “Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma”
by Alba Sanjuan-Sanjuan, Emilia Alors-Perez, Marina Sanchez-Frías, Alicia Dean-Ferrer, Manuel D. Gahete, Susana Heredero-Jung and Raúl M. Luque
Cancers 2021, 13(19), 4828; https://doi.org/10.3390/cancers13194828
Available online: https://www.mdpi.com/2072-6694/13/19/4828

7. “Familial Occurrence of Adult Granulosa Cell Tumors: Analysis of Whole-Genome Germline Variants”
by Joline F. Roze, Joachim Kutzera, Wouter Koole, Margreet G. E. M. Ausems, Kristi Engelstad, Jurgen M. J. Piek, Cor D. de Kroon, René H. M. Verheijen, Gijs van Haaften, Ronald P. Zweemer et al.
Cancers 2021, 13(10), 2430; https://doi.org/10.3390/cancers13102430
Available online: https://www.mdpi.com/2072-6694/13/10/2430

8. “Prognostic Value of Apoptosis-Inducing Factor (AIF) in Germ Cell Tumors”
by Katarina Letkovska, Pavel Babal, Zuzana Cierna, Silvia Schmidtova, Veronika Liskova, Katarína Kalavska, Vera Miskovska, Samuel Horak, Katarina Rejlekova, Michal Chovanec et al.
Cancers 2021, 13(4), 776; https://doi.org/10.3390/cancers13040776
Available online: https://www.mdpi.com/2072-6694/13/4/776

9. “Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model”
by Jinyeong Yu, Sanghyuk Choi, Aran Park, Jungbeom Do, Donghyun Nam, Youngjae Kim, Jinok Noh, Kil Yeon Lee, Chi Hoon Maeng and Ki-Sook Park
Cancers 2021, 13(5), 1059; https://doi.org/10.3390/cancers13051059
Available online: https://www.mdpi.com/2072-6694/13/5/1059

10. “Multiple Myeloma Relapse Is Associated with Increased NFκB Pathway Activity and Upregulation of the Pro-Survival BCL-2 Protein BFL-1”
by Ingrid Spaan, Anja van de Stolpe, Reinier A. Raymakers and Victor Peperzak
Cancers 2021, 13(18), 4668; https://doi.org/10.3390/cancers13184668
Available online: https://www.mdpi.com/2072-6694/13/18/4668

11. “APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma”
by Sarah Siraj, Tariq Masoodi, Abdul K. Siraj, Saud Azam, Zeeshan Qadri, Sandeep K. Parvathareddy, Rong Bu, Khawar S. Siddiqui, Saif S. Al-Sobhi, Mohammed AlDawish et al.
Cancers 2022, 14(6), 1584; https://doi.org/10.3390/cancers14061584
Available online: https://www.mdpi.com/2072-6694/14/6/1584

12. “Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression Analysis”
by Diana J. Z. Dalemans, Sharon Berendsen, Kaspar Draaisma, Pierre A. Robe and Tom J. Snijders
Cancers 2021, 13(15), 3764; https://doi.org/10.3390/cancers13153764
Available online: https://www.mdpi.com/2072-6694/13/15/3764

13. “Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications”
by Jacqueline Schütt, Theresa Nägler, Tino Schenk and Annamaria Brioli
Cancers 2021, 13(16), 4069; https://doi.org/10.3390/cancers13164069
Available online: https://www.mdpi.com/2072-6694/13/16/4069

14. “MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression”
by Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser and Stefan Hüttelmaier
Cancers 2021, 13(23), 5913; https://doi.org/10.3390/cancers13235913
Available online: https://www.mdpi.com/2072-6694/13/23/5913

15. “Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers”
by James Ellegate, Jr., Michalis Mastri, Emily Isenhart, John J. Krolewski, Gurkamal Chatta, Eric Kauffman, Melissa Moffitt and Kevin H. Eng
Cancers 2022, 14(3), 731; https://doi.org/10.3390/cancers14030731
Available online: https://www.mdpi.com/2072-6694/14/3/731

You can check more information about the Section “Cancer Pathophysiology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Pathophysiology.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of cancer causes, screening and diagnosis. The paper list is as follows:

1. “Oncologic Imaging of the Lymphatic System: Current Perspective with Multi-Modality Imaging and New Horizon”
by Mohamed Elshikh, Ahmed W Moawad, Usama Salem, Sergio P Klimkowski, Talaat Hassan, Brinda Rao Korivi, Corey T Jensen, Sanaz Javadi and Khaled M Elsayes
Cancers 2021, 13(18), 4554; https://doi.org/10.3390/cancers13184554
Available online: https://www.mdpi.com/2072-6694/13/18/4554

2. “New Markers of Disease Progression in Myelofibrosis”
by Rita Campanelli, Margherita Massa, Vittorio Rosti and Giovanni Barosi
Cancers 2021, 13(21), 5324; https://doi.org/10.3390/cancers13215324
Available online: https://www.mdpi.com/2072-6694/13/21/5324

3. “Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development”
by Hermine Mohr, Simone Ballke, Nicole Bechmann, Sebastian Gulde, Jaber Malekzadeh-Najafabadi, Mirko Peitzsch, Vasilis Ntziachristos, Katja Steiger, Tobias Wiedemann and Natalia S. Pellegata
Cancers 2021, 13(1), 126; https://doi.org/10.3390/cancers13010126
Available online: https://www.mdpi.com/2072-6694/13/1/126

4. “Recurrent Spliceosome Mutations in Cancer: Mechanisms and Consequences of Aberrant Splice Site Selection”
by Carlos A. Niño, Rossella Scotto di Perrotolo and Simona Polo
Cancers 2022, 14(2), 281; https://doi.org/10.3390/cancers14020281
Available online: https://www.mdpi.com/2072-6694/14/2/281

5. “Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA”
by Wataru Nakajima, Kai Miyazaki, Masahiro Sakaguchi, Yumi Asano, Mariko Ishibashi, Tomoko Kurita, Hiroki Yamaguchi, Hiroyuki Takei and Nobuyuki Tanaka
Cancers 2022, 14(1), 248; https://doi.org/10.3390/cancers14010248
Available online: https://www.mdpi.com/2072-6694/14/1/248

6. “EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)”
by Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, Maurizio Zizzo, Giovanni Martino, Cecilia Caprera, Valentina Fragliasso, Alessandra Soriano, Luca Valle, Stefano Ricci et al.
Cancers 2021, 13(18), 4578; https://doi.org/10.3390/cancers13184578
Available online: https://www.mdpi.com/2072-6694/13/18/4578

7. “Associations between Genetically Predicted Circulating Protein Concentrations and Endometrial Cancer Risk”
by Jingjing Zhu, Tracy A. O’Mara, Duo Liu, Veronica Wendy Setiawan, Dylan Glubb, Amanda B. Spurdle, Peter A. Fasching, Diether Lambrechts, Daniel Buchanan, Pik Fang Kho et al.
Cancers 2021, 13(9), 2088; https://doi.org/10.3390/cancers13092088
Available online: https://www.mdpi.com/2072-6694/13/9/2088

8. “Could Ovarian Cancer Prediction Models Improve the Triage of Symptomatic Women in Primary Care? A Modelling Study Using Routinely Collected Data”
by Garth Funston, Gary Abel, Emma J. Crosbie, Willie Hamilton and Fiona M. Walter
Cancers 2021, 13(12), 2886; https://doi.org/10.3390/cancers13122886
Available online: https://www.mdpi.com/2072-6694/13/12/2886

9. “Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms”
by Ahmed Ebada Salem, Yehia H. Zaki, Gamal El-Hussieny, Khaled I. ElNoueam, Akram M. Shaaban, Bhasker Rao Koppula, Ming Yang, Mohamed Salama, Khaled M. Elsayes and Matthew F. Covington
Cancers 2021, 13(20), 5217; https://doi.org/10.3390/cancers13205217
Available online: https://www.mdpi.com/2072-6694/13/20/5217

10. “Accumulation of Temozolomide-Induced Apoptosis, Senescence and DNA Damage by Metronomic Dose Schedule: A Proof-of-Principle Study with Glioblastoma Cells”
by Lea Beltzig, Björn Stratenwerth and Bernd Kaina
Cancers 2021, 13(24), 6287; https://doi.org/10.3390/cancers13246287
Available online: https://www.mdpi.com/2072-6694/13/24/6287

11. “DNA Methylation in INA, NHLH2, and THBS4 Is Associated with Metastatic Disease in Renal Cell Carcinoma”
by Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M. Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk et al.
Cancers 2022, 14(1), 39; https://doi.org/10.3390/cancers14010039
Available online: https://www.mdpi.com/2072-6694/14/1/39

12. “Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure”
by Ramesh Paudyal, Linda Chen, Jung Hun Oh, Kaveh Zakeri, Vaios Hatzoglou, C. Jillian Tsai, Nancy Lee and Amita Shukla-Dave
Cancers 2021, 13(5), 1128; https://doi.org/10.3390/cancers13051128
Available online: https://www.mdpi.com/2072-6694/13/5/1128

13. “Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer”
by Livingstone Aduse-Poku, Jiang Bian, Dheeraj R. Gopireddy, Mauricio Hernandez, Chandana Lall, Sara M. Falzarano, Shahla Masood, Ara Jo and Ting-Yuan David Cheng
Cancers 2022, 14(7), 1846; https://doi.org/10.3390/cancers14071846
Available online: https://www.mdpi.com/2072-6694/14/7/1846

14. “Preoperative Detection of Liver Involvement by Right-Sided Adrenocortical Carcinoma Using CT and MRI”
by Alice Kedra, Anthony Dohan, Sébastien Gaujoux, Mathilde Sibony, Anne Jouinot, Guillaume Assié, Lionel Groussin Rouiller, Rossella Libé, Jérôme Bertherat, Philippe Soyer et al.
Cancers 2021, 13(7), 1603; https://doi.org/10.3390/cancers13071603
Available online: https://www.mdpi.com/2072-6694/13/7/1603

15. “CT Simplified Radiomic Approach to Assess the Metastatic Ductal Adenocarcinoma of the Pancreas”
by Mirko D’Onofrio, Riccardo De Robertis, Gregorio Aluffi, Camilla Cadore, Alessandro Beleù, Nicolò Cardobi, Giuseppe Malleo, Erminia Manfrin and Claudio Bassi
Cancers 2021, 13(8), 1843; https://doi.org/10.3390/cancers13081843
Available online: https://www.mdpi.com/2072-6694/13/8/1843

You can check more information about the Section “Cancer Causes, Screening and Diagnosis” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Causes_Screening_Diagnosis.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of pediatric oncology. The paper list is as follows:

1. “The New Treatment Methods for Non-Hodgkin Lymphoma in Pediatric Patients”
by Justyna Derebas, Kinga Panuciak, Mikołaj Margas, Joanna Zawitkowska and Monika Lejman
Cancers 2022, 14(6), 1569; https://doi.org/10.3390/cancers14061569
Available online: https://www.mdpi.com/2072-6694/14/6/1569

2. “PPM1D Is a Therapeutic Target in Childhood Neural Tumors”
by Jelena Milosevic, Diana Treis, Susanne Fransson, Gabriel Gallo-Oller, Baldur Sveinbjörnsson, Nina Eissler, Keiji Tanino, Kazuyasu Sakaguchi, Tommy Martinsson, Malin Wickström et al.
Cancers 2021, 13(23), 6042; https://doi.org/10.3390/cancers13236042
Available online: https://www.mdpi.com/2072-6694/13/23/6042

3. “Atypical Teratoid Rhabdoid Tumours Are Susceptible to Panobinostat-Mediated Differentiation Therapy”
by Wai C. Chong, W. Samantha N. Jayasekara, Vijesh G. Vaghjiani, Sarah Parackal, Claire Sun, Dean Popovski, Elizabeth M. Algar, Ron Firestein, Paul J. Wood, Sara Khan et al.
Cancers 2021, 13(20), 5145; https://doi.org/10.3390/cancers13205145
Available online: https://www.mdpi.com/2072-6694/13/20/5145

4. “Prevalence of Sleep Disorders, Risk Factors and Sleep Treatment Needs of Adolescents and Young Adult Childhood Cancer Patients in Follow-Up after Treatment”
by Shosha H. M. Peersmann, Martha A. Grootenhuis, Annemieke van Straten, Gerard A. Kerkhof, Wim J. E. Tissing, Floor Abbink, Andrica C. H. de Vries, Jacqueline Loonen, Leontien C. M. Kremer, Gertjan J. L. Kaspers et al.
Cancers 2022, 14(4), 926; https://doi.org/10.3390/cancers14040926
Available online: https://www.mdpi.com/2072-6694/14/4/926

5. “Parental Sleep, Distress, and Quality of Life in Childhood Acute Lymphoblastic Leukemia: A Longitudinal Report from Diagnosis up to Three Years Later”
by Niki Rensen, Lindsay Steur, Martha Grootenhuis, Jos Twisk, Natasha van Eijkelenburg, Inge van der Sluis, Natasja Dors, Cor van den Bos, Wim Tissing, Gertjan Kaspers et al.
Cancers 2022, 14(11), 2779; https://doi.org/10.3390/cancers14112779
Available online: https://www.mdpi.com/2072-6694/14/11/2779

6. “Maternal Thyroid Disease and the Risk of Childhood Cancer in the Offspring”
by Laura K. Seppälä, Laura-Maria Madanat-Harjuoja, Maarit K. Leinonen, Mitja Lääperi and Kim Vettenranta
Cancers 2021, 13(21), 5409; https://doi.org/10.3390/cancers13215409
Available online: https://www.mdpi.com/2072-6694/13/21/5409

7. “Natural History of Untreated Retinoblastoma”
by Junyang Zhao, Zhaoxun Feng and Brenda L. Gallie
Cancers 2021, 13(15), 3646; https://doi.org/10.3390/cancers13153646
Available online: https://www.mdpi.com/2072-6694/13/15/3646

8. “Concordance of Child Self-Reported and Parent Proxy-Reported Posttraumatic Growth in Childhood Cancer Survivors”
by Veronika Koutná, Marek Blatný and Martin Jelínek
Cancers 2021, 13(16), 4230; https://doi.org/10.3390/cancers13164230
Available online: https://www.mdpi.com/2072-6694/13/16/4230

9. “MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment”
by Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, Silvia Lampis, Andrea Pession, Patrizia Hrelia and Roberto Tonelli
Cancers 2022, 14(18), 4421; https://doi.org/10.3390/cancers14184421
Available online: https://www.mdpi.com/2072-6694/14/18/4421

10. “Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells”
by David King, Harriet E. D. Southgate, Saskia Roetschke, Polly Gravells, Leona Fields, Jessica B. Watson, Lindi Chen, Devon Chapman, Daniel Harrison, Daniel Yeomanson et al.
Cancers 2021, 13(24), 6215; https://doi.org/10.3390/cancers13246215
Available online: https://www.mdpi.com/2072-6694/13/24/6215

11. “Adrenocortical Carcinoma in Childhood: A Systematic Review”
by Maria Riedmeier, Boris Decarolis, Imme Haubitz, Sophie Müller, Konstantin Uttinger, Kevin Börner, Joachim Reibetanz, Armin Wiegering, Christoph Härtel, Paul-Gerhardt Schlegel et al.
Cancers 2021, 13(21), 5266; https://doi.org/10.3390/cancers13215266
Available online: https://www.mdpi.com/2072-6694/13/21/5266

12. “Osteopathic Treatment and Evaluation in the Clinical Setting of Childhood Hematological Malignancies”
by Monica Barbieri, William Zardo, Chiara Frittoli, Clara Rivolta, Valeria Valdata, Federico Bouquin, Greta Passignani, Alberto Maggiani, Momcilo Jankovic, Andrea Cossio et al.
Cancers 2021, 13(24), 6321; https://doi.org/10.3390/cancers13246321
Available online: https://www.mdpi.com/2072-6694/13/24/6321

13. “The Impact of a Precision-Based Exercise Intervention in Childhood Hematological Malignancies Evaluated by an Adapted Yo-Yo Intermittent Recovery Test”
by William Zardo, Emanuele Villa, Eleonora Corti, Tommaso Moriggi, Giorgia Radaelli, Alessandra Ferri, Mauro Marzorati, Cristiano Eirale, Paola Vago, Andrea Biondi et al.
Cancers 2022, 14(5), 1187; https://doi.org/10.3390/cancers14051187
Available online: https://www.mdpi.com/2072-6694/14/5/1187

14. “Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors”
by Silvia Ravera, Tiziana Vigliarolo, Silvia Bruno, Fabio Morandi, Danilo Marimpietri, Federica Sabatini, Monica Dagnino, Andrea Petretto, Martina Bartolucci, Monica Muraca et al.
Cancers 2021, 13(20), 5214; https://doi.org/10.3390/cancers13205214
Available online: https://www.mdpi.com/2072-6694/13/20/5214

15. “Pleuropneumonectomy as Salvage Therapy in Children Suffering from Primary or Metastatic Sarcomas with Pleural Localizations”
by Frédéric Hameury, Perrine Marec-Berard, Mathilde Eymery, Marc H. W. Wijnen, Niels van der Kaaij, Pierre-Yves Mure, François Tronc, Franck Chotel, Clara Libbrecht, Wim Jan P. van Boven et al.
Cancers 2021, 13(15), 3655; https://doi.org/10.3390/cancers13153655
Available online: https://www.mdpi.com/2072-6694/13/15/3655

You can check more information about the Section “Pediatric Oncology” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Pediatric_Oncology.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of infectious agents and cancer. The paper list is as follows:

1. “Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment”
by Adélie Gothland, Valentin Leducq, Philippe Grange, Ousmane Faye, Laurianne Beauvais Remigereau, Sophie Sayon, Nathalie Désiré, Aude Jary, Emmanuel Laplantine, Almoustapha Issiaka Maiga et al.
Cancers 2022, 14(3), 543; https://doi.org/10.3390/cancers14030543
Available online: https://www.mdpi.com/2072-6694/14/3/543

2. “Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Clinical Trial Demographics”
by Tamar M. Gordis, Joshua L. Cagle, Shaun A. Nguyen and Jason G. Newman
Cancers 2022, 14(16), 4061; https://doi.org/10.3390/cancers14164061
Available online: https://www.mdpi.com/2072-6694/14/16/4061

3. “Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC”
by Jacqueline E Mann, Megan L Ludwig, Aditi Kulkarni, Erin B Scheftz, Isabel R Murray, Jingyi Zhai, Elizabeth Gensterblum-Miller, Hui Jiang and J Chad Brenner
Cancers 2021, 13(19), 4782; https://doi.org/10.3390/cancers13194782
Available online: https://www.mdpi.com/2072-6694/13/19/4782

4. “Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective Treatment”
by Susanne Ghandili, Philipp H. von Kroge, Marcel Simon, Frank O. Henes, Holger Rohde, Armin Hoffmann, Nick Benjamin Lindeman, Carsten Bokemeyer, Walter Fiedler and Franziska Modemann
Cancers 2022, 14(11), 2773; https://doi.org/10.3390/cancers14112773
Available online: https://www.mdpi.com/2072-6694/14/11/2773

5. “Dysregulation of Liver Regeneration by Hepatitis B Virus Infection: Impact on Development of Hepatocellular Carcinoma”
by Eun-Sook Park, Mehrangiz Dezhbord, Ah Ram Lee, Bo Bae Park and Kyun-Hwan Kim
Cancers 2022, 14(15), 3566; https://doi.org/10.3390/cancers14153566
Available online: https://www.mdpi.com/2072-6694/14/15/3566

6. “Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma of the Tonsil versus Base of Tongue: A Systematic Review and Meta-Analysis”
by Nicolas S. Poupore, Tiffany Chen, Shaun A. Nguyen, Cherie-Ann O. Nathan and Jason G. Newman
Cancers 2022, 14(15), 3837; https://doi.org/10.3390/cancers14153837
Available online: https://www.mdpi.com/2072-6694/14/15/3837

7. “Interaction of HPV16 and Cutaneous HPV in Head and Neck Cancer”
by Walid A. Al-Soneidar, Sam Harper, Babatunde Y. Alli and Belinda Nicolau
Cancers 2022, 14(21), 5197; https://doi.org/10.3390/cancers14215197
Available online: https://www.mdpi.com/2072-6694/14/21/5197

8. “The Role of Bacteria in KSHV Infection and KSHV-Induced Cancers”
by Ashley Markazi, Wen Meng, Paige M. Bracci, Michael S. McGrath and Shou-Jiang Gao
Cancers 2021, 13(17), 4269; https://doi.org/10.3390/cancers13174269
Available online: https://www.mdpi.com/2072-6694/13/17/4269

9. “DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress”
by Margaret A. Liu
Cancers 2022, 14(23), 5874; https://doi.org/10.3390/cancers14235874
Available online: https://www.mdpi.com/2072-6694/14/23/5874

10. “HPV Infection Leaves a DNA Methylation Signature in Oropharyngeal Cancer Affecting Both Coding Genes and Transposable Elements”
by Diego Camuzi, Luisa Aguirre Buexm, Simone de Queiroz Chaves Lourenço, Davide Degli Esposti, Cyrille Cuenin, Monique de Souza Almeida Lopes, Francesca Manara, Fazlur Rahman Talukdar, Zdenko Herceg, Luis Felipe Ribeiro Pinto et al.
Cancers 2021, 13(14), 3621; https://doi.org/10.3390/cancers13143621
Available online: https://www.mdpi.com/2072-6694/13/14/3621

11. “Patient-Reported Outcomes in Cancer Patients with HIV”
by Anna E. Coghill, Naomi C. Brownstein, Sweta Sinha, Zachary J. Thompson, Brittney L. Dickey, Aasha I. Hoogland, Peter A. Johnstone, Gita Suneja and Heather S. Jim
Cancers 2022, 14(23), 5889; https://doi.org/10.3390/cancers14235889
Available online: https://www.mdpi.com/2072-6694/14/23/5889

12. “Clinical Outcomes in COVID-19 Patients Treated with Immunotherapy”
by Haris Hatic, Kristine R. Hearld, Devika Das and Jessy Deshane
Cancers 2022, 14(23), 5954; https://doi.org/10.3390/cancers14235954
Available online: https://www.mdpi.com/2072-6694/14/23/5954

13. “Aberrant Methylation of Somatostatin Receptor 2 Gene Is Initiated in Aged Gastric Mucosa Infected with Helicobacter pylori and Consequential Gene Silencing Is Associated with Establishment of Inflammatory Microenvironment In Vitro Study”
by Hee-Jin Kim, Jong-Lyul Park, Byoung-Ha Yoon, Keeok Haam, Haejeong Heo, Jong-Hwan Kim, Seon-Young Kim, Mirang Kim, Woo-Ho Kim, Sang-Il Lee et al.
Cancers 2022, 14(24), 6183; https://doi.org/10.3390/cancers14246183
Available online: https://www.mdpi.com/2072-6694/14/24/6183

14. “Effects of Human Papilloma Virus E6/E7 Oncoproteins on Genomic Structure in Head and Neck Squamous Cell Carcinoma”
by Matthew Uzelac, Armon Barakchi, Varsha Beldona, Daniel John, Jaideep Chakladar, Wei Tse Li and Weg M. Ongkeko
Cancers 2022, 14(24), 6190; https://doi.org/10.3390/cancers14246190
Available online: https://www.mdpi.com/2072-6694/14/24/6190

15. “HIV-1 Protease as DNA Immunogen against Drug Resistance in HIV-1 Infection: DNA Immunization with Drug Resistant HIV-1 Protease Protects Mice from Challenge with Protease-Expressing Cells”
by Stefan Petkov, Athina Kilpeläinen, Ekaterina Bayurova, Anastasia Latanova, Dzeina Mezale, Ilse Fridrihsone, Elizaveta Starodubova, Juris Jansons, Alesja Dudorova, Ilya Gordeychuk et al.
Cancers 2023, 15(1), 238; https://doi.org/10.3390/cancers15010238
Available online: https://www.mdpi.com/2072-6694/15/1/238

You can check more information about the Section “Infectious Agents and Cancer” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Infectious_Agents_Cancer.

We are pleased to invite you to read the 2021 and 2022 selected papers in Cancers (ISSN: 2072-6694) on the topic of transplant oncology and cancer nursing care. The paper list is as follows:

1. “Emulation of a Target Trial to Evaluate the Causal Effect of Palliative Care Consultation on the Survival Time of Patients with Hepatocellular Carcinoma”
by Tassaya Buranupakorn, Phaviga Thangsuk, Jayanton Patumanond and Phichayut Phinyo
Cancers 2021, 13(5), 992; https://doi.org/10.3390/cancers13050992
Available online: https://www.mdpi.com/2072-6694/13/5/992

2. “Cost-Effectiveness of Nutrient Supplementation in Cancer Survivors”
by Amy L. Shaver, Theresa A. Tufuor, Jing Nie, Shauna Ekimura, Keri Marshall, Susan Hazels Mitmesser and Katia Noyes
Cancers 2021, 13(24), 6276; https://doi.org/10.3390/cancers13246276
Available online: https://www.mdpi.com/2072-6694/13/24/6276

3. “Colorectal Cancer Anatomical Site and Sleep Quality”
by Mimi Ton, Nathaniel F. Watson, Arthur Sillah, Rachel C. Malen, Julia D. Labadie, Adriana M. Reedy, Stacey A. Cohen, Andrea N. Burnett-Hartman, Polly A. Newcomb and Amanda I. Phipps
Cancers 2021, 13(11), 2578; https://doi.org/10.3390/cancers13112578
Available online: https://www.mdpi.com/2072-6694/13/11/2578

4. “The Role of Prehabilitation in Modern Esophagogastric Cancer Surgery: A Comprehensive Review”
by Augustinas Bausys, Morta Mazeikaite, Klaudija Bickaite, Bernardas Bausys, Rimantas Bausys and Kestutis Strupas
Cancers 2022, 14(9), 2096; https://doi.org/10.3390/cancers14092096
Available online: https://www.mdpi.com/2072-6694/14/9/2096

5. “Can National Tests from the Last Year of Compulsory School Be Used to Obtain More Detailed Information about Academic Performance in Children Treated for Brain Tumours? A Nationwide, Population-Based Study from Sweden”
by Malin Lönnerblad, Eva Berglund, Ingrid van’t Hooft and Klas Blomgren
Cancers 2021, 13(1), 135; https://doi.org/10.3390/cancers13010135
Available online: https://www.mdpi.com/2072-6694/13/1/135

6. “Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway—Results from a Cluster Randomized Trial”
by Marianne Jensen Hjermstad, Julian Hamfjord, Nina Aass, Olav Dajani, Tonje Lundeby, Torunn Wester and Stein Kaasa
Cancers 2021, 13(9), 2194; https://doi.org/10.3390/cancers13092194
Available online: https://www.mdpi.com/2072-6694/13/9/2194

7. “Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?”
by Nicole Tubiana-Mathieu, Thibault Cornette, Stephane Mandigout, Sophie Leobon, François Vincent, Laurence Venat and Elise Deluche
Cancers 2021, 13(22), 5851; https://doi.org/10.3390/cancers13225851
Available online: https://www.mdpi.com/2072-6694/13/22/5851

8. “Identification of Lifestyle Behaviors Associated with Recurrence and Survival in Colorectal Cancer Patients Using Random Survival Forests”
by Moniek van Zutphen, Fränzel J. B. van Duijnhoven, Evertine Wesselink, Ruud W. M. Schrauwen, Ewout A. Kouwenhoven, Henk K. van Halteren, Johannes H. W. de Wilt, Renate M. Winkels, Dieuwertje E. Kok and Hendriek C. Boshuizen
Cancers 2021, 13(10), 2442; https://doi.org/10.3390/cancers13102442
Available online: https://www.mdpi.com/2072-6694/13/10/2442

9. “Medi-Cinema: A Pilot Study on Cinematherapy and Cancer as A New Psychological Approach on 30 Gynecological Oncological Patients”
by Daniela Pia Rosaria Chieffo, Letizia Lafuenti, Ludovica Mastrilli, Rebecca De Paola, Sofia Vannuccini, Marina Morra, Fulvia Salvi, Ivo Boškoski, Vanda Salutari, Gabriella Ferrandina, et al.
Cancers 2022, 14(13), 3067; https://doi.org/10.3390/cancers14133067
Available online: https://www.mdpi.com/2072-6694/14/13/3067

10. “Risk of Pharmacological or Hospital Treatment for Depression in Patients with Colorectal Cancer–Associations with Pre-Cancer Lifestyle, Comorbidity and Clinical Factors”
by Trille Kristina Kjaer, Ida Rask Moustsen-Helms, Vanna Albieri, Signe Benzon Larsen, Thea Helene Degett, Anne Tjønneland, Christoffer Johansen, Susanne K. Kjaer, Ismail Gogenur and Susanne Oksbjerg Dalton
Cancers 2021, 13(8), 1979; https://doi.org/10.3390/cancers13081979
Available online: https://www.mdpi.com/2072-6694/13/8/1979

11. “Maintaining Weight Loss in Obese Men with Prostate Cancer Following a Supervised Exercise and Nutrition Program—A Pilot Study”
by Rebekah L. Wilson, Dennis R. Taaffe, Robert U. Newton, Nicolas H. Hart, Philippa Lyons-Wall and Daniel A. Galvão
Cancers 2021, 13(14), 3411; https://doi.org/10.3390/cancers13143411
Available online: https://www.mdpi.com/2072-6694/13/14/3411

12. ““It’s Always Been a Second Class Cancer”: An Exploration of the Experiences and Journeys of Bereaved Family Carers of People with Sarcoma”
by Moira O’Connor, Greta Smith, Ashleigh Pantaleo, Darren Haywood, Rhys Weaver and Georgia Kb Halkett
Cancers 2021, 13(11), 2670; https://doi.org/10.3390/cancers13112670
Available online: https://www.mdpi.com/2072-6694/13/11/2670

13. “Intra- and Interobserver Variability of Shear Wave Elastography in Rectal Cancer”
by Martina Kastrup Loft, Malene Roland Vils Pedersen, Peter Grimm, Andreas Hoffmann Lauritzen, Claus Dam and Søren Rafael Rafaelsen
Cancers 2022, 14(11), 2633; https://doi.org/10.3390/cancers14112633
Available online: https://www.mdpi.com/2072-6694/14/11/2633

14. “The Extent of Necrosis in Brain Metastases May Predict Subtypes of Primary Cancer and Overall Survival in Patients Receiving Craniotomy”
by Jihwan Yoo, Yoon Jin Cha, Hun Ho Park, Mina Park, Bio Joo, Sang Hyun Suh and Sung Jun Ahn
Cancers 2022, 14(7), 1694; https://doi.org/10.3390/cancers14071694
Available online: https://www.mdpi.com/2072-6694/14/7/1694

15. “The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis”
by Michal Sarfaty, Assaf Moore, Ashley M. Regazzi, Aaron P. Mitchell and Jonathan E. Rosenberg
Cancers 2021, 13(23), 5977; https://doi.org/10.3390/cancers13235977
Available online: https://www.mdpi.com/2072-6694/13/23/5977

You can check more information about the Section “Transplant Oncology and Cancer Nursing Care” in Cancers at the following link: https://www.mdpi.com/journal/cancers/sections/Cancer_Nursing_Care.

We are delighted to share some highly cited papers on anti-cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives”
by Robert Jenke, Nina Reßing, Finn K. Hansen, Achim Aigner and Thomas Büch
Cancers 2021, 13(4), 634; https://doi.org/10.3390/cancers13040634
Available online: https://www.mdpi.com/2072-6694/13/4/634

“3D Cell Culture Models as Recapitulators of the Tumor Microenvironment for the Screening of Anti-Cancer Drugs”
by Mélanie A. G. Barbosa, Cristina P. R. Xavier, Rúben F. Pereira, Vilma Petrikaitė and M. Helena Vasconcelos
Cancers 2022, 14(1), 190; https://doi.org/10.3390/cancers14010190
Available online: https://www.mdpi.com/2072-6694/14/1/190

“Is Emodin with Anticancer Effects Completely Innocent? Two Sides of the Coin”
by Esra Küpeli Akkol, Iffet Irem Tatlı, Gökçe Şeker Karatoprak, Osman Tuncay Ağar, Çiğdem Yücel, Eduardo Sobarzo-Sánchez and Raffaele Capasso
Cancers 2021, 13(11), 2733; https://doi.org/10.3390/cancers13112733
Available online: https://www.mdpi.com/2072-6694/13/11/2733

“Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update”
by Jen-Fu Hsu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang and Ming-Horng Tsai
Cancers 2021, 13(2), 195; https://doi.org/10.3390/cancers13020195
Available online: https://www.mdpi.com/2072-6694/13/2/195

“Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review”
by Sareh Kamran, Ajantha Sinniah, Mahfoudh A. M. Abdulghani and Mohammed Abdullah Alshawsh
Cancers 2022, 14(5), 1100; https://doi.org/10.3390/cancers14051100
Available online: https://www.mdpi.com/2072-6694/14/5/1100

“The Role of Bruton’s Kinase Inhibitors in Chronic Lymphocytic Leukemia: Current Status and Future Directions”
by Tadeusz Robak, Magda Witkowska and Piotr Smolewski
Cancers 2022, 14(3), 771; https://doi.org/10.3390/cancers14030771
Available online: https://www.mdpi.com/2072-6694/14/3/771

“The Renaissance of Cyclin Dependent Kinase Inhibitors”
by Tobias Ettl, Daniela Schulz and Richard Josef Bauer
Cancers 2022, 14(2), 293; https://doi.org/10.3390/cancers14020293
Available online: https://www.mdpi.com/2072-6694/14/2/293

We hope this announcement will provide useful information for this field.

The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030. 

To commemorate the World Hepatitis Day 2023, MDPI is launching a special webinar to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis.

We are looking forward to seeing you at the MDPI World Hepatitis Day Webinar 2023. 

Conference secretariat: Ms. Shun Li
Date and time: 28 July 2023, 7:00 a.m. and 3:00 p.m., CEST

This is a free webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized. 

Unable to attend? Register anyway and we will let you know when the recording is available to watch. 

Session 1:

Register for Session 1 for free!

Session 2:

Register for Session 2 for free! 

Relevant Special Issues:
Pathogens
"Research on Hepatitis B Virus: Past, Present, and Future"
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023 

JPM
"Novel Challenges and Therapeutic Options for Liver Diseases"
Edited by: Guido Gerken
Submission deadline: 30 September 2023 

Medicina
"Viral Hepatitis Research: Updates and Challenges"
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023 

Cells
"Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States"
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024 

Diagnostics
"Diagnosis and Management of Liver Diseases—2nd Edition"
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023 

Vaccines
"Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives"
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023

A range of MDPI journals will be attending the 2023 BMES Annual Meeting as exhibitors. This meeting will be held in Seattle, USA, from 11 to 14 October 2023.

The BMES Annual Meeting will gather participants for networking, education, and continued growth in the biomedical engineering field. It is a premiere event centered around topics and discussions specific to our community. The theme of this year’s meeting is focused on the convergence of three pillars essential to our field’s success: science, technology, and social transformation.

The conference's vision is to center the perspective that the future of biomedical engineering requires and the curious evaluation of complex scientific challenges, while candidly considering intersectionality and social factors. Through creative programming, it will ensure that these three pillars are interwoven into all aspects of the meeting.

The following MDPI journals will be represented:

• Bioengineering;
• Biomedicines;
• Biomimetics;
• Cancers;
• CIMB;
• Diseases;
• Micromachines;
• Biosensors.

If you are attending this conference, please feel free to start a conversation with us at our booth at #931. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.bmes.org/annualmeeting.

We are delighted to share some highly cited papers on methods and technologies development that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Artificial Intelligence for Thyroid Nodule Characterization: Where Are We Standing?”
by Salvatore Sorrenti, Vincenzo Dolcetti, Maija Radzina, Maria Irene Bellini, Fabrizio Frezza, Khushboo Munir, Giorgio Grani, Cosimo Durante, Vito D’Andrea, Emanuele David et al.
Cancers 2022, 14(14), 3357; https://doi.org/10.3390/cancers14143357
Available online: https://www.mdpi.com/2072-6694/14/14/3357

“A Review of Circulating Tumour Cell Enrichment Technologies”
by Amelia J. Rushton, Georgios Nteliopoulos, Jacqueline A. Shaw and R. Charles Coombes
Cancers 2021, 13(5), 970; https://doi.org/10.3390/cancers13050970
Available online: https://www.mdpi.com/2072-6694/13/5/970

“Novel Transfer Learning Approach for Medical Imaging with Limited Labeled Data”
by Laith Alzubaidi, Muthana Al-Amidie, Ahmed Al-Asadi, Amjad J. Humaidi, Omran Al-Shamma, Mohammed A. Fadhel, Jinglan Zhang, J. Santamaría and Ye Duan
Cancers 2021, 13(7), 1590; https://doi.org/10.3390/cancers13071590
Available online: https://www.mdpi.com/2072-6694/13/7/1590

“Organoid and Spheroid Tumor Models: Techniques and Applications”
by Sreenivasulu Gunti, Austin T. K. Hoke, Kenny P. Vu and Nyall R. London, Jr.
Cancers 2021, 13(4), 874; https://doi.org/10.3390/cancers13040874
Available online: https://www.mdpi.com/2072-6694/13/4/874

“Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field”
by Fernanda Andrade, Maria Mercé Roca-Melendres, Esteban F. Durán-Lara, Diana Rafael and Simó Schwartz, Jr.
Cancers 2021, 13(5), 1164; https://doi.org/10.3390/cancers13051164
Available online: https://www.mdpi.com/2072-6694/13/5/1164

“Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for Cancer Diagnosis, Target Drug Delivery, and Treatment”
by Sumaira Anjum, Mariam Hashim, Sara Asad Malik, Maha Khan, José M. Lorenzo, Bilal Haider Abbasi and Christophe Hano
Cancers 2021, 13(18), 4570; https://doi.org/10.3390/cancers13184570
Available online: https://www.mdpi.com/2072-6694/13/18/4570

We hope this announcement will provide useful information for this field.

With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.

The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.

Please feel free to browse and discover more about the new journals below.

Journal	Founding Editor-in-Chief	Journal topics (selected)
	Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue	growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article
	Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue	DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article
	Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue	lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article
	Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue	multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article
	Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue	Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.

We are delighted to share some highly cited papers that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

“Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer”
by Se-Young Park, Byeong-Oh Hwang, Mihwa Lim, Seung-Ho Ok, Sun-Kyoung Lee, Kyung-Soo Chun, Kwang-Kyun Park, Yinling Hu, Won-Yoon Chung and Na-Young Song
Cancers 2021, 13(9), 2124; https://doi.org/10.3390/cancers13092124
Available online: https://www.mdpi.com/2072-6694/13/9/2124

“Determination of Exosome Mitochondrial DNA as a Biomarker of Renal Cancer Aggressiveness”
by Elena Arance, Viviana Ramírez, Alejandro Rubio-Roldan, Francisco M. Ocaña-Peinado, Catalina Romero-Cachinero, Ana Belén Jódar-Reyes, Fernando Vazquez-Alonso, Luis Javier Martinez-Gonzalez and Maria Jesus Alvarez-Cubero
Cancers 2022, 14(1), 199; https://www.mdpi.com/2072-6694/14/1/199
Available online: https://www.mdpi.com/2072-6694/14/1/199

“Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network”
by Li Zhou, Maria Rueda and Abedalrhman Alkhateeb
Cancers 2022, 14(4), 934; https://doi.org/10.3390/cancers14040934
Available online: https://www.mdpi.com/2072-6694/14/4/934

“The Evolution of Ovarian Carcinoma Subclassification”
by Martin Köbel and Eun Young Kang
Cancers 2022, 14(2), 416; https://doi.org/10.3390/cancers14020416
Available online: https://www.mdpi.com/2072-6694/14/2/416

“The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis”
by Giorgio Ivan Russo, Nicolò Musso, Alessandra Romano, Giuseppe Caruso, Salvatore Petralia, Luca Lanzanò, Giuseppe Broggi and Massimo Camarda
Cancers 2022, 14(1), 198; https://doi.org/10.3390/cancers14010198
Available online: https://www.mdpi.com/2072-6694/14/1/198

“Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany”
by Louis Jacob, Sven H. Loosen, Matthias Kalder, Tom Luedde, Christoph Roderburg and Karel Kostev
Cancers 2021, 13(3), 408; https://doi.org/10.3390/cancers13030408
Available online: https://www.mdpi.com/2072-6694/13/3/408

“Chemotherapy Side-Effects: Not All DNA Damage Is Equal”
by Winnie M. C. van den Boogaard, Daphne S. J. Komninos and Wilbert P. Vermeij
Cancers 2022, 14(3), 627; https://doi.org/10.3390/cancers14030627
Available online: https://www.mdpi.com/2072-6694/14/3/627

“Timely Palliative Care: Personalizing the Process of Referral”
by David Hui, Yvonne Heung and Eduardo Bruera
Cancers 2022, 14(4), 1047; https://doi.org/10.3390/cancers14041047
Available online: https://www.mdpi.com/2072-6694/14/4/1047

We hope this announcement will provide useful information for this field.

We are delighted to share some highly cited papers on breast cancer research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will be of interest to you.

“Breast Tumour Classification Using Ultrasound Elastography with Machine Learning: A Systematic Scoping Review”
by Ye-Jiao Mao, Hyo-Jung Lim, Ming Ni, Wai-Hin Yan, Duo Wai-Chi Wong and James Chung-Wai Cheung
Cancers 2022, 14(2), 367; https://doi.org/10.3390/cancers14020367
Available online: https://www.mdpi.com/2072-6694/14/2/367

“Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application”
by Dulla Naveen Kumar, Aiswarya Chaudhuri, Farrukh Aqil, Deepa Dehari, Radha Munagala, Sanjay Singh, Ramesh C. Gupta and Ashish Kumar Agrawal
Cancers 2022, 14(6), 1435; https://doi.org/10.3390/cancers14061435
Available online: https://www.mdpi.com/2072-6694/14/6/1435

“Role of ctDNA in Breast Cancer”
by Marta Sant, Adrià Bernat-Peguera, Eudald Felip and Mireia Margelí
Cancers 2022, 14(2), 310; https://doi.org/10.3390/cancers14020310
Available online: https://www.mdpi.com/2072-6694/14/2/310

“Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021”
by Maroun Bou Zerdan, Tala Ghorayeb, Fares Saliba, Sabine Allam, Morgan Bou Zerdan, Marita Yaghi, Nadeem Bilani, Rola Jaafar and Zeina Nahleh
Cancers 2022, 14(5), 1253; https://doi.org/10.3390/cancers14051253
Available online: https://www.mdpi.com/2072-6694/14/5/1253

“HER2-Low Breast Cancer: Molecular Characteristics and Prognosis”
by Elisa Agostinetto, Mattia Rediti, Danai Fimereli, Véronique Debien, Martine Piccart, Philippe Aftimos, Christos Sotiriou and Evandro de Azambuja
Cancers 2021, 13(11), 2824; https://doi.org/10.3390/cancers13112824
Available online: https://www.mdpi.com/2072-6694/13/11/2824

“Molecular Targets of Triple-Negative Breast Cancer: Where Do We Stand?”
by Emma E. Newton, Lauren E. Mueller, Scout M. Treadwell, Cindy A. Morris and Heather L. Machado
Cancers 2022, 14(3), 482; https://doi.org/10.3390/cancers14030482
Available online: https://www.mdpi.com/2072-6694/14/3/482

We hope this announcement will provide useful information for this field.

We are delighted to share some highly cited papers on cancer resistance research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you. The list of relevant papers can be seen below:

“Mechanisms of Resistance to KRAS^G12C Inhibitors”
by Victoria Dunnett-Kane, Pantelis Nicola, Fiona Blackhall and Colin Lindsay
Cancers 2021, 13(1), 151; https://doi.org/10.3390/cancers13010151
Available online: https://www.mdpi.com/2072-6694/13/1/151

“Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance”
by Christiana M. Neophytou, Ioannis P. Trougakos, Nuray Erin and Panagiotis Papageorgis
Cancers 2021, 13(17), 4363; https://doi.org/10.3390/cancers13174363
Available online: https://www.mdpi.com/2072-6694/13/17/4363

“Mechanisms of Resistance to Conventional Therapies for Osteosarcoma”
by Louise Marchandet, Morgane Lallier, Céline Charrier, Marc Baud’huin, Benjamin Ory and François Lamoureux
Cancers 2021, 13(4), 683; https://doi.org/10.3390/cancers13040683
Available online: https://www.mdpi.com/2072-6694/13/4/683

“Immune Resistance in Lung Adenocarcinoma”
by Magda Spella and Georgios T. Stathopoulos
Cancers 2021, 13(3), 384; https://doi.org/10.3390/cancers13030384
Available online: https://www.mdpi.com/2072-6694/13/3/384

“Recent Insights into Therapy Resistance in Osteosarcoma”
by Zachary D. Prudowsky and Jason T. Yustein
Cancers 2021, 13(1), 83; https://doi.org/10.3390/cancers13010083
Available online: https://www.mdpi.com/2072-6694/13/1/83

“EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance”
by Mary Luz Uribe, Ilaria Marrocco and Yosef Yarden
Cancers 2021, 13(11), 2748; https://doi.org/10.3390/cancers13112748
Available online: https://www.mdpi.com/2072-6694/13/11/2748

Special Issues:

We are pleased to share that Cancers (ISSN: 2072-6694) was awarded an Impact Factor of 5.2 in the 2022 Journal Citation Reports™ released by Clarivate in June 2023. Cancers ranks in Q2 (72 among 241 titles) in the the “Oncology” category.

For further statistics, please visit https://www.mdpi.com/journal/cancers/stats.

The support and dedication of all journal editors, reviewers, authors, and readers are essential to our excellent performance. Thank you to everyone who has contributed to and supported our journal.

We are delighted to share some highly cited papers on cancer epidemiology and prevention that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission.

“Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies”
by Md. Sanower Hossain, Hidayah Karuniawati, Ammar Abdulrahman Jairoun, Zannat Urbi, Der Jiun Ooi, Akbar John, Ya Chee Lim, K. M. Kaderi Kibria, A. K. M. Mohiuddin, Long Chiau Ming et al.
Cancers 2022, 14(7), 1732; https://doi.org/10.3390/cancers14071732
Available online: https://www.mdpi.com/2072-6694/14/7/1732

“A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis”
by Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz and Katarzyna E. Przybyłowicz
Cancers 2021, 13(9), 2025; https://doi.org/10.3390/cancers13092025
Available online: https://www.mdpi.com/2072-6694/13/9/2025

“Epidemiology of Glioblastoma Multiforme–Literature Review”
by Szymon Grochans, Anna Maria Cybulska, Donata Simińska, Jan Korbecki, Klaudyna Kojder, Dariusz Chlubek and Irena Baranowska-Bosiacka
Cancers 2022, 14(10), 2412; https://doi.org/10.3390/cancers14102412
Available online: https://www.mdpi.com/2072-6694/14/10/2412

“Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review”
by Sergiusz Łukasiewicz, Marcin Czeczelewski, Alicja Forma, Jacek Baj, Robert Sitarz and Andrzej Stanisławek
Cancers 2021, 13(17), 4287; https://doi.org/10.3390/cancers13174287
Available online: https://www.mdpi.com/2072-6694/13/17/4287

“Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries”
by Junjie Huang, Anastasios Koulaouzidis, Wojciech Marlicz, Veeleah Lok, Cedric Chu, Chun Ho Ngai, Lin Zhang, Ping Chen, Shanjuan Wang, Jinqiu Yuan et al.
Cancers 2021, 13(1), 141; https://doi.org/10.3390/cancers13010141
Available online: https://www.mdpi.com/2072-6694/13/1/141

We hope this announcement will provide useful information for this field.

We are delighted to share some highly cited papers on cancer therapy research that were published in the journal Cancers (ISSN: 2072-6694) in 2021 and 2022. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues which we believe will be of interest to you.

"STING Agonists as Cancer Therapeutics"
by Afsaneh Amouzegar, Manoj Chelvanambi, Jessica N. Filderman, Walter J. Storkus and Jason J. Luke
Cancers 2021, 13(11), 2695; https://doi.org/10.3390/cancers13112695
Available online: https://www.mdpi.com/2072-6694/13/11/2695

"MMP9: A Tough Target for Targeted Therapy for Cancer"
by Katarzyna Augoff, Anita Hryniewicz-Jankowska, Renata Tabola and Kamilla Stach
Cancers 2022, 14(7), 1847; https://doi.org/10.3390/cancers14071847
Available online: https://www.mdpi.com/2072-6694/14/7/1847

"Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives"
by Nora Berois, Alvaro Pittini and Eduardo Osinaga
Cancers 2022, 14(3), 645; https://doi.org/10.3390/cancers14030645
Available online: https://www.mdpi.com/2072-6694/14/3/645

"The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment"
by Keiko Taguchi and Masayuki Yamamoto
Cancers 2021, 13(1), 46; https://doi.org/10.3390/cancers13010046
Available online: https://www.mdpi.com/2072-6694/13/1/46

"Photodynamic Therapy: A Compendium of Latest Reviews"
by José Francisco Algorri, Mario Ochoa, Pablo Roldán-Varona, Luís Rodríguez-Cobo and José Miguel López-Higuera
Cancers 2021, 13(17), 4447; https://doi.org/10.3390/cancers13174447
Available online: https://www.mdpi.com/2072-6694/13/17/4447

"Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives"
by Cristina Birzu, Pim French, Mario Caccese, Giulia Cerretti, Ahmed Idbaih, Vittorina Zagonel and Giuseppe Lombardi
Cancers 2021, 13(1), 47; https://doi.org/10.3390/cancers13010047
Available online: https://www.mdpi.com/2072-6694/13/1/47

"Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives"
by Shirin Hafezi and Mohamed Rahmani
Cancers 2021, 13(6), 1292; https://doi.org/10.3390/cancers13061292
Available online: https://www.mdpi.com/2072-6694/13/6/1292

We hope this announcement will provide useful information for this field.

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.

The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.

The following MDPI journals will be represented:

• Cancers;
• JCM;
• Cells;
• Diagnostics;
• Medical Sciences;
• Biomedicines;
• Geriatrics;
• Current Oncology;
• Hemato;
• Onco;
• CIMB;
• Healthcare.

If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.